R-HSA-168276; NS1 Mediated Effects on Host Pathways
R-HSA-164843;2-LTR circle formation
R-HSA-73843;5-Phosphoribose 1-diphosphate biosynthesis
R-HSA-1971475;A tetrasaccharide linker sequence is required for GAG synthesis
R-HSA-5619084;ABC transporter disorders
R-HSA-1369062;ABC transporters in lipid homeostasis
R-HSA-382556;ABC-family proteins mediated transport
R-HSA-418592;ADP signalling through P2Y purinoceptor 1
R-HSA-392170;ADP signalling through P2Y purinoceptor 12
R-HSA-198323;AKT phosphorylates targets in the cytosol
R-HSA-198693;AKT phosphorylates targets in the nucleus
R-HSA-211163;AKT-mediated inactivation of FOXO1A
R-HSA-112122;ALKBH2 mediated reversal of alkylation damage
R-HSA-112126;ALKBH3 mediated reversal of alkylation damage
R-HSA-4839748;AMER1 mutants destabilize the destruction complex
R-HSA-163680;AMPK inhibits chREBP transcriptional activation activity
R-HSA-5467333;APC truncation mutants are not K63 polyubiquitinated
R-HSA-5467337;APC truncation mutants have impaired AXIN binding
R-HSA-179409;APC-Cdc20 mediated degradation of Nek2A
R-HSA-174143;APC/C-mediated degradation of cell cycle proteins
R-HSA-174048;APC/C:Cdc20 mediated degradation of Cyclin B
R-HSA-174154;APC/C:Cdc20 mediated degradation of Securin
R-HSA-176409;APC/C:Cdc20 mediated degradation of mitotic proteins
R-HSA-174178;APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
R-HSA-179419;APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
R-HSA-5649702;APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway
R-HSA-180689;APOBEC3G mediated resistance to HIV-1 infection
R-HSA-5624958;ARL13B-mediated ciliary trafficking of INPP5E
R-HSA-170984;ARMS-mediated activation
R-HSA-380994;ATF4 activates genes
R-HSA-381183;ATF6 (ATF6-alpha) activates chaperone genes
R-HSA-381033;ATF6 (ATF6-alpha) activates chaperones
R-HSA-1296025;ATP sensitive Potassium channels
R-HSA-450408;AUF1 (hnRNP D0) binds and destabilizes mRNA
R-HSA-8854518;AURKA Activation by TPX2
R-HSA-5467340;AXIN missense mutants destabilize the destruction complex
R-HSA-4839735;AXIN mutants destabilize the destruction complex, activating WNT signaling
R-HSA-2161541;Abacavir metabolism
R-HSA-2161517;Abacavir transmembrane transport
R-HSA-2161522;Abacavir transport and metabolism
R-HSA-73930;Abasic sugar-phosphate removal via the single-nucleotide replacement pathway
R-HSA-2978092;Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate
R-HSA-167242;Abortive elongation of HIV-1 transcript in the absence of Tat
R-HSA-156582;Acetylation
R-HSA-264642;Acetylcholine Neurotransmitter Release Cycle
R-HSA-181431;Acetylcholine binding and downstream events
R-HSA-399997;Acetylcholine regulates insulin secretion
R-HSA-1300645;Acrosome Reaction
R-HSA-2122948;Activated NOTCH1 Transmits Signal to the Nucleus
R-HSA-5625886;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3
R-HSA-166054;Activated TLR4 signalling
R-HSA-2033519;Activated point mutants of FGFR2
R-HSA-111452;Activation and oligomerization of BAK protein
R-HSA-165158;Activation of AKT2
R-HSA-399710;Activation of AMPA receptors
R-HSA-176814;Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
R-HSA-176187;Activation of ATR in response to replication stress
R-HSA-111447;Activation of BAD and translocation to mitochondria 
R-HSA-114452;Activation of BH3-only proteins
R-HSA-111446;Activation of BIM and translocation to mitochondria 
R-HSA-139910;Activation of BMF and translocation to mitochondria
R-HSA-174577;Activation of C3 and C5
R-HSA-451308;Activation of Ca-permeable Kainate Receptor
R-HSA-442745;Activation of CaMK IV
R-HSA-211227;Activation of DNA fragmentation factor
R-HSA-539107;Activation of E2F1 target genes at G1/S
R-HSA-1296041;Activation of G protein gated Potassium channels
R-HSA-991365;Activation of GABAB receptors
R-HSA-5619507;Activation of HOX genes during differentiation
R-HSA-936964;Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
R-HSA-1592389;Activation of Matrix Metalloproteinases
R-HSA-1169091;Activation of NF-kappaB in B cells
R-HSA-2980767;Activation of NIMA Kinases NEK9, NEK6, NEK7
R-HSA-442755;Activation of NMDA receptor and postsynaptic events
R-HSA-111448;Activation of NOXA and translocation to mitochondria
R-HSA-451307;Activation of Na-permeable kainate receptors
R-HSA-629602;Activation of Nicotinic Acetylcholine Receptors
R-HSA-2151209;Activation of PPARGC1A (PGC-1alpha) by phosphorylation
R-HSA-139915;Activation of PUMA and translocation to mitochondria
R-HSA-428540;Activation of RAC1
R-HSA-1169092;Activation of RAS in B cells
R-HSA-5635838;Activation of SMO
R-HSA-187015;Activation of TRKA receptors
R-HSA-5617472;Activation of anterior HOX genes in hindbrain development during early embryogenesis
R-HSA-111459;Activation of caspases through apoptosome-mediated cleavage
R-HSA-2426168;Activation of gene expression by SREBF (SREBP)
R-HSA-451326;Activation of kainate receptors upon glutamate binding
R-HSA-450341;Activation of the AP-1 family of transcription factors
R-HSA-8866907;Activation of the TFAP2 (AP-2) family of transcription factors
R-HSA-72662;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S
R-HSA-2485179;Activation of the phototransduction cascade
R-HSA-68962;Activation of the pre-replicative complex
R-HSA-75108;Activation, myristolyation of BID and translocation to mitochondria
R-HSA-114294;Activation, translocation and oligomerization of BAX
R-HSA-1482798;Acyl chain remodeling of CL
R-HSA-1482883;Acyl chain remodeling of DAG and TAG
R-HSA-1482788;Acyl chain remodelling of PC
R-HSA-1482839;Acyl chain remodelling of PE
R-HSA-1482925;Acyl chain remodelling of PG
R-HSA-1482922;Acyl chain remodelling of PI
R-HSA-1482801;Acyl chain remodelling of PS
R-HSA-1280218;Adaptive Immune System
R-HSA-417973;Adenosine P1 receptors
R-HSA-170660;Adenylate cyclase activating pathway
R-HSA-170670;Adenylate cyclase inhibitory pathway
R-HSA-418990;Adherens junctions interactions
R-HSA-392023;Adrenaline signalling through Alpha-2 adrenergic receptor
R-HSA-400042;Adrenaline,noradrenaline inhibits insulin secretion
R-HSA-390696;Adrenoceptors
R-HSA-879415;Advanced glycosylation endproduct receptor signaling
R-HSA-5423646;Aflatoxin activation and detoxification
R-HSA-351143;Agmatine biosynthesis
R-HSA-1462054;Alpha-defensins
R-HSA-389599;Alpha-oxidation of phytanate
R-HSA-173736;Alternative complement activation
R-HSA-140179;Amine Oxidase reactions
R-HSA-375280;Amine ligand-binding receptors
R-HSA-209776;Amine-derived hormones
R-HSA-156587;Amino Acid conjugation
R-HSA-70614;Amino acid synthesis and interconversion (transamination)
R-HSA-352230;Amino acid transport across the plasma membrane
R-HSA-141444;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal
R-HSA-141424;Amplification of signal from the kinetochores
R-HSA-977225;Amyloid fiber formation
R-HSA-2214320;Anchoring fibril formation
R-HSA-5620912;Anchoring of the basal body to the plasma membrane
R-HSA-193048;Androgen biosynthesis
R-HSA-2473224;Antagonism of Activin by Follistatin
R-HSA-983170;Antigen Presentation: Folding, assembly and peptide loading of class I MHC
R-HSA-983695;Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
R-HSA-1236975;Antigen processing-Cross presentation
R-HSA-983168;Antigen processing: Ubiquitination & Proteasome degradation
R-HSA-6803157;Antimicrobial peptides
R-HSA-1169410;Antiviral mechanism by IFN-stimulated genes
R-HSA-109581;Apoptosis
R-HSA-140342;Apoptosis induced DNA fragmentation
R-HSA-351906;Apoptotic cleavage of cell adhesion  proteins
R-HSA-111465;Apoptotic cleavage of cellular proteins
R-HSA-75153;Apoptotic execution  phase
R-HSA-111471;Apoptotic factor-mediated response
R-HSA-445717;Aquaporin-mediated transport
R-HSA-426048;Arachidonate production from DAG
R-HSA-2142753;Arachidonic acid metabolism
R-HSA-211957;Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2
R-HSA-8937144;Aryl hydrocarbon receptor signalling
R-HSA-446203;Asparagine N-linked glycosylation
R-HSA-175474;Assembly Of The HIV Virion
R-HSA-168316;Assembly of Viral Components at the Budding Site
R-HSA-8963889;Assembly of active LPL and LIPC lipase complexes
R-HSA-2022090;Assembly of collagen fibrils and other multimeric structures
R-HSA-68616;Assembly of the ORC complex at the origin of replication
R-HSA-68867;Assembly of the pre-replicative complex
R-HSA-390471;Association of TriC/CCT with target proteins during biosynthesis
R-HSA-69298;Association of licensing factors with the pre-replicative complex
R-HSA-210455;Astrocytic Glutamate-Glutamine Uptake And Metabolism
R-HSA-4608870;Asymmetric localization of PCP proteins
R-HSA-162791;Attachment of GPI anchor to uPAR
R-HSA-3371568;Attenuation phase
R-HSA-174084;Autodegradation of Cdh1 by Cdh1:APC/C
R-HSA-349425;Autodegradation of the E3 ubiquitin ligase COP1
R-HSA-177539;Autointegration results in viral DNA circles
R-HSA-422475;Axon guidance
R-HSA-193634;Axonal growth inhibition (RHOA activation)
R-HSA-209563;Axonal growth stimulation
R-HSA-5250924;B-WICH complex positively regulates rRNA expression
R-HSA-5620922;BBSome-mediated cargo-targeting to cilium
R-HSA-111453;BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
R-HSA-1368108;BMAL1:CLOCK,NPAS2 activates circadian gene expression
R-HSA-73884;Base Excision Repair
R-HSA-73929;Base-Excision Repair, AP Site Formation
R-HSA-210991;Basigin interactions
R-HSA-1461957;Beta defensins
R-HSA-77352;Beta oxidation of butanoyl-CoA to acetyl-CoA
R-HSA-77346;Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA
R-HSA-77350;Beta oxidation of hexanoyl-CoA to butanoyl-CoA
R-HSA-77310;Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA
R-HSA-77285;Beta oxidation of myristoyl-CoA to lauroyl-CoA
R-HSA-77348;Beta oxidation of octanoyl-CoA to hexanoyl-CoA
R-HSA-77305;Beta oxidation of palmitoyl-CoA to myristoyl-CoA
R-HSA-3858494;Beta-catenin independent WNT signaling
R-HSA-196299;Beta-catenin phosphorylation cascade
R-HSA-389887;Beta-oxidation of pristanoyl-CoA
R-HSA-390247;Beta-oxidation of very long chain fatty acids
R-HSA-425381;Bicarbonate transporters
R-HSA-194068;Bile acid and bile salt metabolism
R-HSA-2173782;Binding and Uptake of Ligands by Scavenger Receptors
R-HSA-173107;Binding and entry of HIV virion
R-HSA-4411364;Binding of TCF/LEF:CTNNB1 to target gene promoters
R-HSA-141333;Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB
R-HSA-211859;Biological oxidations
R-HSA-2466712;Biosynthesis of A2E, implicated in retinal degradation
R-HSA-446193;Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein
R-HSA-196780;Biotin transport and metabolism
R-HSA-70895;Branched-chain amino acid catabolism
R-HSA-352238;Breakdown of the nuclear lamina
R-HSA-168302;Budding
R-HSA-162588;Budding and maturation of HIV virion
R-HSA-450385;Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
R-HSA-8851680;Butyrophilin (BTN) family interactions
R-HSA-5621481;C-type lectin receptors (CLRs)
R-HSA-75102;C6 deamination of adenosine
R-HSA-5218900;CASP8 activity is inhibited
R-HSA-5621575;CD209 (DC-SIGN) signaling
R-HSA-5690714;CD22 mediated BCR regulation
R-HSA-389356;CD28 co-stimulation
R-HSA-389357;CD28 dependent PI3K/Akt signaling
R-HSA-389359;CD28 dependent Vav1 pathway
R-HSA-68689;CDC6 association with the ORC:origin complex
R-HSA-69017;CDK-mediated phosphorylation and removal of Cdc6
R-HSA-375170;CDO in myogenesis
R-HSA-68827;CDT1 association with the CDC6:ORC:origin complex
R-HSA-447041;CHL1 interactions
R-HSA-5607763;CLEC7A (Dectin-1) induces NFAT activation
R-HSA-5607764;CLEC7A (Dectin-1) signaling
R-HSA-5660668;CLEC7A/inflammasome pathway
R-HSA-6811434;COPI-dependent Golgi-to-ER retrograde traffic
R-HSA-6811436;COPI-independent Golgi-to-ER retrograde traffic
R-HSA-6807878;COPI-mediated anterograde transport
R-HSA-204005;COPII (Coat Protein 2) Mediated Vesicle Transport
R-HSA-140180;COX reactions
R-HSA-199920;CREB phosphorylation
R-HSA-442720;CREB phosphorylation through the activation of Adenylate Cyclase
R-HSA-442729;CREB phosphorylation through the activation of CaMKII
R-HSA-442717;CREB phosphorylation through the activation of CaMKK
R-HSA-442742;CREB phosphorylation through the activation of Ras
R-HSA-8874211;CREB3 factors activate genes
R-HSA-399956;CRMPs in Sema3A signaling
R-HSA-2024101;CS/DS degradation
R-HSA-389513;CTLA4 inhibitory signaling
R-HSA-211999;CYP2E1 reactions
R-HSA-111996;Ca-dependent events
R-HSA-1296052;Ca2+ activated K+ channels
R-HSA-4086398;Ca2+ pathway
R-HSA-111997;CaM pathway
R-HSA-111932;CaMK IV-mediated phosphorylation of CREB
R-HSA-2025928;Calcineurin activates NFAT
R-HSA-419812;Calcitonin-like ligand receptors
R-HSA-111933;Calmodulin induced events
R-HSA-901042;Calnexin/calreticulin cycle
R-HSA-111957;Cam-PDE 1 activation
R-HSA-72737;Cap-dependent Translation Initiation
R-HSA-8955332;Carboxyterminal post-translational modifications of tubulin
R-HSA-5576891;Cardiac conduction
R-HSA-5694530;Cargo concentration in the ER
R-HSA-8856825;Cargo recognition for clathrin-mediated endocytosis
R-HSA-5620920;Cargo trafficking to the periciliary membrane
R-HSA-71262;Carnitine synthesis
R-HSA-5357769;Caspase activation via extrinsic apoptotic signalling pathway
R-HSA-264870;Caspase-mediated cleavage of cytoskeletal proteins
R-HSA-5661270;Catabolism of glucuronate to xylulose-5-phosphate
R-HSA-209905;Catecholamine biosynthesis
R-HSA-426117;Cation-coupled Chloride cotransporters
R-HSA-174184;Cdc20:Phospho-APC/C mediated degradation of Cyclin A
R-HSA-1640170;Cell Cycle
R-HSA-69620;Cell Cycle Checkpoints
R-HSA-69278;Cell Cycle, Mitotic
R-HSA-204998;Cell death signalling via NRAGE, NRIF and NADE
R-HSA-446728;Cell junction organization
R-HSA-1222541;Cell redox homeostasis
R-HSA-202733;Cell surface interactions at the vascular wall
R-HSA-1500931;Cell-Cell communication
R-HSA-421270;Cell-cell junction organization
R-HSA-446353;Cell-extracellular matrix interactions
R-HSA-2559583;Cellular Senescence
R-HSA-189200;Cellular hexose transport
R-HSA-3371556;Cellular response to heat stress
R-HSA-2262749;Cellular response to hypoxia
R-HSA-8953897;Cellular responses to external stimuli
R-HSA-2262752;Cellular responses to stress
R-HSA-380287;Centrosome maturation
R-HSA-193681;Ceramide signalling
R-HSA-163765;ChREBP activates metabolic gene expression
R-HSA-390466;Chaperonin-mediated protein folding
R-HSA-380108;Chemokine receptors bind chemokines
R-HSA-75035;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
R-HSA-191273;Cholesterol biosynthesis
R-HSA-6807047;Cholesterol biosynthesis via desmosterol
R-HSA-6807062;Cholesterol biosynthesis via lathosterol
R-HSA-6798163;Choline catabolism
R-HSA-2022870;Chondroitin sulfate biosynthesis
R-HSA-1793185;Chondroitin sulfate/dermatan sulfate metabolism
R-HSA-3247509;Chromatin modifying enzymes
R-HSA-4839726;Chromatin organization
R-HSA-73886;Chromosome Maintenance
R-HSA-8963888;Chylomicron assembly
R-HSA-8964026;Chylomicron clearance
R-HSA-8963901;Chylomicron remodeling
R-HSA-5617833;Cilium Assembly
R-HSA-400253;Circadian Clock
R-HSA-71403;Citric acid cycle (TCA cycle)
R-HSA-373076;Class A/1 (Rhodopsin-like receptors)
R-HSA-373080;Class B/2 (Secretin family receptors)
R-HSA-420499;Class C/3 (Metabotropic glutamate/pheromone receptors)
R-HSA-983169;Class I MHC mediated antigen processing & presentation
R-HSA-1296053;Classical Kir channels
R-HSA-173623;Classical antibody-mediated complement activation
R-HSA-421837;Clathrin derived vesicle budding
R-HSA-8856828;Clathrin-mediated endocytosis
R-HSA-2993913;Clearance of Nuclear Envelope Membranes from Chromatin
R-HSA-109688;Cleavage of Growing Transcript in the Termination Region 
R-HSA-110331;Cleavage of the damaged purine
R-HSA-110329;Cleavage of the damaged pyrimidine 
R-HSA-196741;Cobalamin (Cbl, vitamin B12) transport and metabolism
R-HSA-196783;Coenzyme A biosynthesis
R-HSA-2470946;Cohesin Loading onto Chromatin
R-HSA-1650814;Collagen biosynthesis and modifying enzymes
R-HSA-8948216;Collagen chain trimerization
R-HSA-1442490;Collagen degradation
R-HSA-1474290;Collagen formation
R-HSA-140875;Common Pathway of Fibrin Clot Formation
R-HSA-8948700;Competing endogenous RNAs (ceRNAs) regulate PTEN translation
R-HSA-166658;Complement cascade
R-HSA-6799198;Complex I biogenesis
R-HSA-2514853;Condensation of Prometaphase Chromosomes
R-HSA-2299718;Condensation of Prophase Chromosomes
R-HSA-177135;Conjugation of benzoate with glycine
R-HSA-159424;Conjugation of carboxylic acids
R-HSA-177162;Conjugation of phenylacetate with glutamine
R-HSA-177128;Conjugation of salicylate with glycine
R-HSA-5674400;Constitutive Signaling by AKT1 E17K in Cancer
R-HSA-2219530;Constitutive Signaling by Aberrant PI3K in Cancer
R-HSA-5637810;Constitutive Signaling by EGFRvIII
R-HSA-1236382;Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
R-HSA-2691232;Constitutive Signaling by NOTCH1 HD Domain Mutants
R-HSA-2894862;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
R-HSA-2644606;Constitutive Signaling by NOTCH1 PEST Domain Mutants
R-HSA-2660826;"Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"
R-HSA-176407;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
R-HSA-6814122;Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
R-HSA-389958;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding
R-HSA-388841;Costimulation by the CD28 family
R-HSA-71288;Creatine metabolism
R-HSA-166786;Creation of C4 and C2 activators
R-HSA-8949613;Cristae formation
R-HSA-1236973;Cross-presentation of particulate exogenous antigens (phagosomes)
R-HSA-1236978;Cross-presentation of soluble exogenous antigens (endosomes)
R-HSA-2243919;Crosslinking of collagen fibrils
R-HSA-69273;Cyclin A/B1/B2 associated events during G2/M transition
R-HSA-69656;Cyclin A:Cdk2-associated events at S phase entry
R-HSA-69231;Cyclin D associated events in G1
R-HSA-69202;Cyclin E associated events during G1/S transition 
R-HSA-1614603;Cysteine formation from homocysteine
R-HSA-211897;Cytochrome P450 - arranged by substrate type
R-HSA-111461;Cytochrome c-mediated apoptotic response
R-HSA-1280215;Cytokine Signaling in Immune system
R-HSA-2564830;Cytosolic iron-sulfur cluster assembly
R-HSA-1834949;Cytosolic sensors of pathogen-associated DNA 
R-HSA-156584;Cytosolic sulfonation of small molecules
R-HSA-379716;Cytosolic tRNA aminoacylation
R-HSA-1489509;DAG and IP3 signaling
R-HSA-2172127;DAP12 interactions
R-HSA-2424491;DAP12 signaling
R-HSA-180024;DARPP-32 events
R-HSA-418885;DCC mediated attractive signaling
R-HSA-168928;DDX58/IFIH1-mediated induction of interferon-alpha/beta
R-HSA-3134963;DEx/H-box helicases activate type I IFN and inflammatory cytokines production 
R-HSA-73893;DNA Damage Bypass
R-HSA-5696394;DNA Damage Recognition in GG-NER
R-HSA-73942;DNA Damage Reversal
R-HSA-2559586;DNA Damage/Telomere Stress Induced Senescence
R-HSA-5693606;DNA Double Strand Break Response
R-HSA-5693532;DNA Double-Strand Break Repair
R-HSA-73894;DNA Repair
R-HSA-69306;DNA Replication
R-HSA-69002;DNA Replication Pre-Initiation
R-HSA-5334118;DNA methylation
R-HSA-68952;DNA replication initiation
R-HSA-69190;DNA strand elongation
R-HSA-376172;DSCAM interactions
R-HSA-3769402;Deactivation of the beta-catenin transactivating complex
R-HSA-429947;Deadenylation of mRNA
R-HSA-429914;Deadenylation-dependent mRNA decay
R-HSA-73887;Death Receptor Signalling
R-HSA-5607761;Dectin-1 mediated noncanonical NF-kB signaling
R-HSA-5621480;Dectin-2 family
R-HSA-5682113;Defective ABCA1 causes Tangier disease
R-HSA-5682294;Defective ABCA12 causes autosomal recessive congenital ichthyosis type 4B
R-HSA-5688399;Defective ABCA3 causes pulmonary surfactant metabolism dysfunction 3 (SMDP3)
R-HSA-5683678;Defective ABCA3 causes pulmonary surfactant metabolism dysfunction type 3 (SMDP3)
R-HSA-5678520;Defective ABCB11 causes progressive familial intrahepatic cholestasis 2 and benign recurrent intrahepatic cholestasis 2
R-HSA-5678771;Defective ABCB4 causes progressive familial intrahepatic cholestasis 3, intrahepatic cholestasis of pregnancy 3 and gallbladder disease 1
R-HSA-5683371;Defective ABCB6 causes isolated colobomatous microphthalmia 7 (MCOPCB7)
R-HSA-5679001;Defective ABCC2 causes Dubin-Johnson syndrome
R-HSA-5690338;Defective ABCC6 causes pseudoxanthoma elasticum (PXE)
R-HSA-5683177;Defective ABCC8 can cause hypoglycemias and hyperglycemias
R-HSA-5678420;Defective ABCC9 causes dilated cardiomyopathy 10, familial atrial fibrillation 12 and hypertrichotic osteochondrodysplasia
R-HSA-5684045;Defective ABCD1 causes adrenoleukodystrophy (ALD)
R-HSA-5683329;Defective ABCD4 causes methylmalonic aciduria and homocystinuria, cblj type (MAHCJ)
R-HSA-5679096;Defective ABCG5 causes sitosterolemia
R-HSA-5679090;Defective ABCG8 causes gallbladder disease 4 and sitosterolemia
R-HSA-5579031;Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)
R-HSA-5579007;Defective ACY1 causes encephalopathy
R-HSA-5578997;Defective AHCY causes Hypermethioninemia with S-adenosylhomocysteine hydrolase deficiency (HMAHCHD)
R-HSA-4549380;Defective ALG1 causes ALG1-CDG (CDG-1k)
R-HSA-4551295;Defective ALG11 causes ALG11-CDG (CDG-1p)
R-HSA-4720489;Defective ALG12 causes ALG12-CDG (CDG-1g)
R-HSA-5633231;Defective ALG14 causes congenital myasthenic syndrome (ALG14-CMS)
R-HSA-4549349;Defective ALG2 causes ALG2-CDG (CDG-1i)
R-HSA-4720475;Defective ALG3 causes ALG3-CDG (CDG-1d)
R-HSA-4724289;Defective ALG6 causes ALG6-CDG (CDG-1c)
R-HSA-4724325;Defective ALG8 causes ALG8-CDG (CDG-1h)
R-HSA-4720454;Defective ALG9 causes ALG9-CDG (CDG-1l)
R-HSA-3359462;Defective AMN causes hereditary megaloblastic anemia 1
R-HSA-5619099;Defective AVP causes neurohypophyseal diabetes insipidus (NDI)
R-HSA-4420332;Defective B3GALT6 causes EDSP2 and SEMDJL1
R-HSA-5083635;Defective B3GALTL causes Peters-plus syndrome (PpS)
R-HSA-3560801;Defective B3GAT3 causes JDSSDHD
R-HSA-3656244;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
R-HSA-4793953;Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)
R-HSA-3560783;Defective B4GALT7 causes EDS, progeroid type
R-HSA-3371598;Defective BTD causes biotidinase deficiency
R-HSA-5083632;Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)
R-HSA-3359485;Defective CD320 causes methylmalonic aciduria
R-HSA-5678895;Defective CFTR causes cystic fibrosis
R-HSA-3595174;Defective CHST14 causes EDS, musculocontractural type
R-HSA-3595172;Defective CHST3 causes SEDCJD
R-HSA-3656225;Defective CHST6 causes MCDC1
R-HSA-3595177;Defective CHSY1 causes TPBS
R-HSA-5619060;Defective CP causes aceruloplasminemia (ACERULOP)
R-HSA-5688890;Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)
R-HSA-5688849;Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)
R-HSA-3359463;Defective CUBN causes hereditary megaloblastic anemia 1
R-HSA-5579026;Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
R-HSA-5579017;Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
R-HSA-5579009;Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
R-HSA-5579028;Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
R-HSA-5579030;Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
R-HSA-5579000;Defective CYP1B1 causes Glaucoma
R-HSA-5579021;Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
R-HSA-5579010;Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
R-HSA-5579015;Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
R-HSA-5579004;Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
R-HSA-5578996;Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
R-HSA-5579014;Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
R-HSA-5579027;Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
R-HSA-5579011;Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
R-HSA-5579005;Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
R-HSA-5579013;Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
R-HSA-4755609;Defective DHDDS causes retinitis pigmentosa 59
R-HSA-4755583;Defective DOLK causes DOLK-CDG (CDG-1m)
R-HSA-4549356;Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2
R-HSA-4717374;Defective DPM1 causes DPM1-CDG (CDG-1e)
R-HSA-4719377;Defective DPM2 causes DPM2-CDG (CDG-1u)
R-HSA-4719360;Defective DPM3 causes DPM3-CDG (CDG-1o)
R-HSA-3656253;Defective EXT1 causes exostoses 1, TRPS2 and CHDS
R-HSA-3656237;Defective EXT2 causes exostoses 2
R-HSA-5579019;Defective FMO3 causes Trimethylaminuria (TMAU)
R-HSA-5609977;Defective GALE can cause Epimerase-deficiency galactosemia (EDG)
R-HSA-5609976;Defective GALK1 can cause Galactosemia II (GALCT2)
R-HSA-5083636;Defective GALNT12 causes colorectal cancer 1 (CRCS1)
R-HSA-5083625;Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)
R-HSA-5609978;Defective GALT can cause Galactosemia
R-HSA-5619073;Defective GCK causes maturity-onset diabetes of the young 2 (MODY2)
R-HSA-5578999;Defective GCLC causes Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency (HAGGSD)
R-HSA-4085023;Defective GFPT1 causes CMSTA1
R-HSA-5579022;Defective GGT1 causes Glutathionuria (GLUTH)
R-HSA-3359457;Defective GIF causes intrinsic factor deficiency
R-HSA-4085011;Defective GNE causes sialuria, Nonaka myopathy and inclusion body myopathy 2
R-HSA-5579006;Defective GSS causes Glutathione synthetase deficiency (GSS deficiency)
R-HSA-5619056;Defective HK1 causes hexokinase deficiency (HK deficiency)
R-HSA-3371599;Defective HLCS causes multiple carboxylase deficiency
R-HSA-5083627;Defective LARGE causes MDDGA6 and MDDGB6
R-HSA-5083630;Defective LFNG causes SCDO3
R-HSA-3359458;Defective LMBRD1 causes methylmalonic aciduria and homocystinuria type cblF
R-HSA-4793950;Defective MAN1B1 causes MRT15
R-HSA-5579012;Defective MAOA causes Brunner syndrome (BRUNS)
R-HSA-5579024;Defective MAT1A causes Methionine adenosyltransferase deficiency (MATD)
R-HSA-4793952;Defective MGAT2 causes MGAT2-CDG (CDG-2a)
R-HSA-3359475;Defective MMAA causes methylmalonic aciduria type cblA
R-HSA-3359471;Defective MMAB causes methylmalonic aciduria type cblB
R-HSA-3359474;Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC
R-HSA-3359473;Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD
R-HSA-4793954;Defective MOGS causes MOGS-CDG (CDG-2b)
R-HSA-4687000;Defective MPDU1 causes MPDU1-CDG (CDG-1f)
R-HSA-4043916;Defective MPI causes MPI-CDG (CDG-1b)
R-HSA-3359469;Defective MTR causes methylmalonic aciduria and homocystinuria type cblG
R-HSA-3359467;Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE
R-HSA-3359478;Defective MUT causes methylmalonic aciduria mut type
R-HSA-5545483;Defective Mismatch Repair Associated With MLH1
R-HSA-5632928;Defective Mismatch Repair Associated With MSH2
R-HSA-5632927;Defective Mismatch Repair Associated With MSH3
R-HSA-5632968;Defective Mismatch Repair Associated With MSH6
R-HSA-5632987;Defective Mismatch Repair Associated With PMS2
R-HSA-4341670;Defective NEU1 causes sialidosis
R-HSA-5578998;Defective OPLAH causes 5-oxoprolinase deficiency (OPLAHD)
R-HSA-3560796;Defective PAPSS2 causes SEMD-PA
R-HSA-5609974;Defective PGM1 causes PGM1-CDG (CDG1t)
R-HSA-4043911;Defective PMM2 causes PMM2-CDG (CDG-1a)
R-HSA-5083628;Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3
R-HSA-5083633;Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1
R-HSA-5083629;Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2
R-HSA-4570571;Defective RFT1 causes RFT1-CDG (CDG-1n)
R-HSA-5619042;Defective RHAG causes regulator type Rh-null hemolytic anemia (RHN)
R-HSA-5687868;Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)
R-HSA-5619048;Defective SLC11A2 causes hypochromic microcytic anemia, with iron overload 1 (AHMIO1)
R-HSA-5619104;Defective SLC12A1 causes Bartter syndrome 1 (BS1)
R-HSA-5619087;Defective SLC12A3 causes Gitelman syndrome (GS)
R-HSA-5619039;Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN)
R-HSA-5619070;Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT)
R-HSA-5619035;Defective SLC17A5 causes Salla disease (SD) and ISSD
R-HSA-5619076;Defective SLC17A8 causes autosomal dominant deafness 25 (DFNA25)
R-HSA-5619067;Defective SLC1A1 is implicated in schizophrenia 18 (SCZD18) and dicarboxylic aminoaciduria (DCBXA)
R-HSA-5619062;Defective SLC1A3 causes episodic ataxia 6 (EA6)
R-HSA-5619111;Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1)
R-HSA-5619071;Defective SLC22A12 causes renal hypouricemia 1 (RHUC1)
R-HSA-5619066;Defective SLC22A18 causes lung cancer (LNCR) and embryonal rhabdomyosarcoma 1 (RMSE1)
R-HSA-5619053;Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP)
R-HSA-5619077;Defective SLC24A1 causes congenital stationary night blindness 1D (CSNB1D)
R-HSA-5619055;Defective SLC24A4 causes hypomineralized amelogenesis imperfecta (AI)
R-HSA-5619036;Defective SLC24A5 causes oculocutaneous albinism 6 (OCA6)
R-HSA-3560792;Defective SLC26A2 causes chondrodysplasias
R-HSA-5619085;Defective SLC26A3 causes congenital secretory chloride diarrhea 1 (DIAR1)
R-HSA-5619046;Defective SLC26A4 causes Pendred syndrome (PDS)
R-HSA-5619108;Defective SLC27A4 causes ichthyosis prematurity syndrome (IPS)
R-HSA-5619063;Defective SLC29A3 causes histiocytosis-lymphadenopathy plus syndrome (HLAS)
R-HSA-5619043;Defective SLC2A1 causes GLUT1 deficiency syndrome 1 (GLUT1DS1)
R-HSA-5619068;Defective SLC2A10 causes arterial tortuosity syndrome (ATS)
R-HSA-5619098;Defective SLC2A2 causes Fanconi-Bickel syndrome (FBS)
R-HSA-5619047;Defective SLC2A9 causes hypouricemia renal 2 (RHUC2)
R-HSA-5619061;Defective SLC33A1 causes spastic paraplegia 42 (SPG42)
R-HSA-5619040;Defective SLC34A1 causes hypophosphatemic nephrolithiasis/osteoporosis 1 (NPHLOP1)
R-HSA-5687583;Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)
R-HSA-5619045;Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM)
R-HSA-5619097;Defective SLC34A3 causes Hereditary hypophosphatemic rickets with hypercalciuria (HHRH)
R-HSA-5619037;Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
R-HSA-5663020;Defective SLC35A1 causes congenital disorder of glycosylation 2F (CDG2F)
R-HSA-5619072;Defective SLC35A2 causes congenital disorder of glycosylation 2M (CDG2M)
R-HSA-5619083;Defective SLC35A3 causes arthrogryposis, mental retardation, and seizures (AMRS)
R-HSA-5619078;Defective SLC35C1 causes congenital disorder of glycosylation 2C (CDG2C)
R-HSA-5579020;Defective SLC35D1 causes Schneckenbecken dysplasia (SCHBCKD)
R-HSA-5619041;Defective SLC36A2 causes iminoglycinuria (IG) and hyperglycinuria (HG)
R-HSA-5619088;Defective SLC39A4 causes acrodermatitis enteropathica, zinc-deficiency type (AEZ)
R-HSA-5619113;Defective SLC3A1 causes cystinuria (CSNU)
R-HSA-5655799;Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum)
R-HSA-5619049;Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages)
R-HSA-5619050;Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4),  distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)
R-HSA-5619054;Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA)
R-HSA-5656364;Defective SLC5A1 causes congenital glucose/galactose malabsorption (GGM)
R-HSA-5658208;Defective SLC5A2 causes renal glucosuria (GLYS1)
R-HSA-5619096;Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1)
R-HSA-5658471;Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)
R-HSA-5619114;Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A)
R-HSA-5659729;Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria
R-HSA-5619079;Defective SLC6A18 may confer susceptibility to iminoglycinuria and/or hyperglycinuria
R-HSA-5659735;Defective SLC6A19 causes Hartnup disorder (HND)
R-HSA-5619044;Defective SLC6A19 causes Hartnup disorder (HND)
R-HSA-5619109;Defective SLC6A2 causes orthostatic intolerance (OI)
R-HSA-5619081;Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
R-HSA-5660724;Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
R-HSA-5619089;Defective SLC6A5 causes hyperekplexia 3 (HKPX3)
R-HSA-5660862;Defective SLC7A7 causes lysinuric protein intolerance (LPI)
R-HSA-5660883;Defective SLC7A9 causes cystinuria (CSNU)
R-HSA-5619092;Defective SLC9A6 causes  X-linked, syndromic mental retardation,, Christianson type (MRXSCH)
R-HSA-5619052;Defective SLC9A9 causes autism 16 (AUTS16)
R-HSA-5661182;Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)
R-HSA-5619110;Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)
R-HSA-5619058;Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)
R-HSA-5619095;Defective SLCO2A1 causes primary, autosomal recessive hypertrophic osteoarthropathy 2 (PHOAR2)
R-HSA-4755579;Defective SRD5A3 causes SRD5A3-CDG (CDG-1q) and KHRZ
R-HSA-3656243;Defective ST3GAL3 causes MCT12 and EIEE15
R-HSA-5579032;Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
R-HSA-3359454;Defective TCN2 causes hereditary megaloblastic anemia
R-HSA-5578995;Defective TPMT causes Thiopurine S-methyltransferase deficiency (TPMT deficiency)
R-HSA-5619107;Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
R-HSA-5579002;Defective UGT1A1 causes hyperbilirubinemia
R-HSA-5579016;Defective UGT1A4 causes hyperbilirubinemia
R-HSA-5688031;Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)
R-HSA-5688354;Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)
R-HSA-3323169;Defects in biotin (Btn) metabolism
R-HSA-3296469;Defects in cobalamin (B12) metabolism
R-HSA-3296482;Defects in vitamin and cofactor metabolism
R-HSA-1461973;Defensins
R-HSA-4641257;Degradation of AXIN
R-HSA-4641258;Degradation of DVL
R-HSA-916853;Degradation of GABA
R-HSA-5610780;Degradation of GLI1 by the proteasome
R-HSA-5610783;Degradation of GLI2 by the proteasome
R-HSA-195253;Degradation of beta-catenin by the destruction complex
R-HSA-1614558;Degradation of cysteine and homocysteine
R-HSA-1474228;Degradation of the extracellular matrix
R-HSA-5467343;Deletions in the AMER1 gene destabilize the destruction complex
R-HSA-5467345;Deletions in the AXIN genes in hepatocellular carcinoma result in elevated WNT signaling
R-HSA-4419969;Depolymerisation of the Nuclear Lamina
R-HSA-606279;Deposition of new CENPA-containing nucleosomes at the centromere
R-HSA-73927;Depurination
R-HSA-73928;Depyrimidination
R-HSA-8862803;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
R-HSA-2022923;Dermatan sulfate biosynthesis
R-HSA-3299685;Detoxification of Reactive Oxygen Species
R-HSA-5688426;Deubiquitination
R-HSA-1266738;Developmental Biology
R-HSA-8935690;Digestion
R-HSA-8963743;Digestion and absorption
R-HSA-189085;Digestion of dietary carbohydrate
R-HSA-192456;Digestion of dietary lipid
R-HSA-69416;Dimerization of procaspase-8
R-HSA-4641262;Disassembly of the destruction complex and recruitment of AXIN to the membrane
R-HSA-1643685;Disease
R-HSA-3781860;Diseases associated with N-glycosylation of proteins
R-HSA-3906995;Diseases associated with O-glycosylation of proteins
R-HSA-3560782;Diseases associated with glycosaminoglycan metabolism
R-HSA-5609975;Diseases associated with glycosylation precursor biosynthesis
R-HSA-5687613;Diseases associated with surfactant metabolism
R-HSA-5602358;Diseases associated with the TLR signaling cascade
R-HSA-2474795;Diseases associated with visual transduction
R-HSA-5260271;Diseases of Immune System
R-HSA-5423599;Diseases of Mismatch Repair (MMR)
R-HSA-5663084;Diseases of carbohydrate metabolism
R-HSA-3781865;Diseases of glycosylation
R-HSA-5668914;Diseases of metabolism
R-HSA-5663202;Diseases of signal transduction
R-HSA-114516;Disinhibition of SNARE formation
R-HSA-5619115;Disorders of transmembrane transporters
R-HSA-110357;Displacement of DNA glycosylase by APEX1
R-HSA-75205;Dissolution of Fibrin Clot
R-HSA-212676;Dopamine Neurotransmitter Release Cycle
R-HSA-379401;Dopamine clearance from the synaptic cleft
R-HSA-390651;Dopamine receptors
R-HSA-8863795;Downregulation of ERBB2 signaling
R-HSA-1358803;Downregulation of ERBB2:ERBB3 signaling
R-HSA-1253288;Downregulation of ERBB4 signaling
R-HSA-2173795;Downregulation of SMAD2/3:SMAD4 transcriptional activity
R-HSA-2173788;Downregulation of TGF-beta receptor signaling
R-HSA-202424;Downstream TCR signaling
R-HSA-186763;Downstream signal transduction
R-HSA-1168372;Downstream signaling events of B Cell Receptor (BCR)
R-HSA-5654687;Downstream signaling of activated FGFR1
R-HSA-5654696;Downstream signaling of activated FGFR2
R-HSA-5654708;Downstream signaling of activated FGFR3
R-HSA-5654716;Downstream signaling of activated FGFR4
R-HSA-5696400;Dual Incision in GG-NER
R-HSA-6782135;Dual incision in TC-NER
R-HSA-113510;E2F mediated regulation of DNA replication
R-HSA-113507;E2F-enabled inhibition of pre-replication complex formation
R-HSA-8866654;E3 ubiquitin ligases ubiquitinate target proteins
R-HSA-3000178;ECM proteoglycans
R-HSA-2179392;EGFR Transactivation by Gastrin
R-HSA-182971;EGFR downregulation
R-HSA-212718;EGFR interacts with phospholipase C-gamma
R-HSA-2682334;EPH-Ephrin signaling
R-HSA-3928665;EPH-ephrin mediated repulsion of cells
R-HSA-3928663;EPHA-mediated growth cone collapse
R-HSA-3928662;EPHB-mediated forward signaling
R-HSA-901032;ER Quality Control Compartment (ERQC)
R-HSA-199977;ER to Golgi Anterograde Transport
R-HSA-1236974;ER-Phagosome pathway
R-HSA-8847993;ERBB2 Activates PTK6 Signaling
R-HSA-6785631;ERBB2 Regulates Cell Motility
R-HSA-427389;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
R-HSA-198753;ERK/MAPK targets
R-HSA-202670;ERKs are inactivated
R-HSA-162594;Early Phase of HIV Life Cycle
R-HSA-114508;Effects of PIP2 hydrolysis
R-HSA-391903;Eicosanoid ligand-binding receptors
R-HSA-211979;Eicosanoids
R-HSA-1566948;Elastic fibre formation
R-HSA-112303;Electric Transmission Across Gap Junctions
R-HSA-2395516;Electron transport from NADPH to Ferredoxin
R-HSA-139853;Elevation of cytosolic Ca2+ levels
R-HSA-211976;Endogenous sterols
R-HSA-917729;Endosomal Sorting Complex Required For Transport (ESCRT)
R-HSA-1236977;Endosomal/Vacuolar pathway
R-HSA-380972;Energy dependent regulation of mTOR by LKB1-AMPK
R-HSA-168275;Entry of Influenza Virion into Host Cell via Endocytosis
R-HSA-379398;Enzymatic degradation of Dopamine by monoamine oxidase
R-HSA-379397;Enzymatic degradation of dopamine by COMT
R-HSA-3928664;Ephrin signaling
R-HSA-212165;Epigenetic regulation of gene expression
R-HSA-1237044;Erythrocytes take up carbon dioxide and release oxygen
R-HSA-1247673;Erythrocytes take up oxygen and release carbon dioxide
R-HSA-5657562;Essential fructosuria
R-HSA-5662853;Essential pentosuria
R-HSA-2468052;Establishment of Sister Chromatid Cohesion
R-HSA-193144;Estrogen biosynthesis
R-HSA-71384;Ethanol oxidation
R-HSA-156842;Eukaryotic Translation Elongation
R-HSA-72613;Eukaryotic Translation Initiation
R-HSA-72764;Eukaryotic Translation Termination
R-HSA-168274;Export of Viral Ribonucleoproteins from Nucleus
R-HSA-180786;Extension of Telomeres
R-HSA-1474244;Extracellular matrix organization
R-HSA-140834;Extrinsic Pathway of Fibrin Clot Formation
R-HSA-8854050;FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
R-HSA-2644605;FBXW7 Mutants and NOTCH1 in Cancer
R-HSA-2871809;FCERI mediated Ca+2 mobilization
R-HSA-2871796;FCERI mediated MAPK activation
R-HSA-2871837;FCERI mediated NF-kB activation
R-HSA-2029481;FCGR activation
R-HSA-190242;FGFR1 ligand binding and activation
R-HSA-1839124;FGFR1 mutant receptor activation
R-HSA-190370;FGFR1b ligand binding and activation
R-HSA-190374;FGFR1c and Klotho ligand binding and activation
R-HSA-190373;FGFR1c ligand binding and activation
R-HSA-6803529;FGFR2 alternative splicing
R-HSA-190241;FGFR2 ligand binding and activation
R-HSA-1839126;FGFR2 mutant receptor activation
R-HSA-190377;FGFR2b ligand binding and activation
R-HSA-190375;FGFR2c ligand binding and activation
R-HSA-190239;FGFR3 ligand binding and activation
R-HSA-2033514;FGFR3 mutant receptor activation
R-HSA-190371;FGFR3b ligand binding and activation
R-HSA-190372;FGFR3c ligand binding and activation
R-HSA-190322;FGFR4 ligand binding and activation
R-HSA-1839128;FGFR4 mutant receptor activation
R-HSA-5658623;FGFRL1 modulation of FGFR1 signaling
R-HSA-217271;FMO oxidises nucleophiles
R-HSA-5654693;FRS-mediated FGFR1 signaling
R-HSA-5654700;FRS-mediated FGFR2 signaling
R-HSA-5654706;FRS-mediated FGFR3 signaling
R-HSA-5654712;FRS-mediated FGFR4 signaling
R-HSA-983231;Factors involved in megakaryocyte development and platelet production
R-HSA-6783310;Fanconi Anemia Pathway
R-HSA-75157;FasL/ CD95L signaling
R-HSA-434316;Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
R-HSA-8978868;Fatty acid metabolism
R-HSA-211935;Fatty acids
R-HSA-75105;Fatty acyl-CoA biosynthesis
R-HSA-2454202;Fc epsilon receptor (FCERI) signaling
R-HSA-2029480;Fcgamma receptor (FCGR) dependent phagocytosis
R-HSA-1187000;Fertilization
R-HSA-1566977;Fibronectin matrix formation
R-HSA-2855086;Ficolins bind to repetitive carbohydrate structures on the target cell surface
R-HSA-390450;Folding of actin by CCT/TriC
R-HSA-163210;Formation of ATP by chemiosmotic coupling
R-HSA-140877;Formation of Fibrin Clot (Clotting Cascade)
R-HSA-167152;Formation of HIV elongation complex in the absence of HIV Tat
R-HSA-167200;Formation of HIV-1 elongation complex containing HIV-1 Tat
R-HSA-5696395;Formation of Incision Complex in GG-NER
R-HSA-112382;Formation of RNA Pol II elongation complex 
R-HSA-2559584;Formation of Senescence-Associated Heterochromatin Foci (SAHF)
R-HSA-6781823;Formation of TC-NER Pre-Incision Complex
R-HSA-72689;Formation of a pool of free 40S subunits
R-HSA-196025;Formation of annular gap junctions
R-HSA-111458;Formation of apoptosome
R-HSA-77042;Formation of editosomes by ADAR proteins
R-HSA-2408499;Formation of selenosugars for excretion
R-HSA-113418;Formation of the Early Elongation Complex
R-HSA-75094;Formation of the Editosome
R-HSA-167158;Formation of the HIV-1 Early Elongation Complex
R-HSA-173599;Formation of the active cofactor, UDP-glucuronate
R-HSA-201722;Formation of the beta-catenin:TCF transactivating complex
R-HSA-6809371;Formation of the cornified envelope
R-HSA-72695;Formation of the ternary complex, and subsequently, the 43S complex
R-HSA-389960;Formation of tubulin folding intermediates by CCT/TriC
R-HSA-444473;Formyl peptide receptors bind formyl peptides and many other ligands
R-HSA-444209;Free fatty acid receptors
R-HSA-400451;Free fatty acids regulate insulin secretion
R-HSA-170968;Frs2-mediated activation
R-HSA-5652227;Fructose biosynthesis
R-HSA-70350;Fructose catabolism
R-HSA-5652084;Fructose metabolism
R-HSA-168270;Fusion and Uncoating of the Influenza Virion
R-HSA-168288;Fusion of the Influenza Virion to the Host Cell Endosome
R-HSA-416482;G alpha (12/13) signalling events
R-HSA-418594;G alpha (i) signalling events
R-HSA-416476;G alpha (q) signalling events
R-HSA-418555;G alpha (s) signalling events
R-HSA-418597;G alpha (z) signalling events
R-HSA-392451;G beta:gamma signalling through PI3Kgamma
R-HSA-418217;G beta:gamma signalling through PLC beta
R-HSA-1296059;G protein gated Potassium channels
R-HSA-202040;G-protein activation
R-HSA-397795;G-protein beta:gamma signalling
R-HSA-112040;G-protein mediated events
R-HSA-1538133;G0 and Early G1
R-HSA-69236;G1 Phase
R-HSA-69615;G1/S DNA Damage Checkpoints
R-HSA-69206;G1/S Transition
R-HSA-69205;G1/S-Specific Transcription
R-HSA-68911;G2 Phase
R-HSA-69481;G2/M Checkpoints
R-HSA-69473;G2/M DNA damage checkpoint
R-HSA-69478;G2/M DNA replication checkpoint
R-HSA-69275;G2/M Transition
R-HSA-180292;GAB1 signalosome
R-HSA-977442;GABA A (rho) receptor activation
R-HSA-977441;GABA A receptor activation
R-HSA-977444;GABA B receptor activation
R-HSA-977443;GABA receptor activation
R-HSA-888568;GABA synthesis
R-HSA-888590;GABA synthesis, release, reuptake and degradation
R-HSA-6787639;GDP-fucose biosynthesis
R-HSA-5635851;GLI proteins bind promoters of Hh responsive genes to promote transcription
R-HSA-5610785;GLI3 is processed to GLI3R by the proteasome
R-HSA-430116;GP1b-IX-V activation signalling
R-HSA-388396;GPCR downstream signalling
R-HSA-500792;GPCR ligand binding
R-HSA-114604;GPVI-mediated activation cascade
R-HSA-179812;GRB2 events in EGFR signaling
R-HSA-1963640;GRB2 events in ERBB2 signaling
R-HSA-354194;GRB2:SOS provides linkage to MAPK signaling for Integrins 
R-HSA-1306955;GRB7 events in ERBB2 signaling
R-HSA-72706;GTP hydrolysis and joining of the 60S ribosomal subunit
R-HSA-70370;Galactose catabolism
R-HSA-163841;Gamma carboxylation, hypusine formation and arylsulfatase activation
R-HSA-159740;Gamma-carboxylation of protein precursors
R-HSA-159854;Gamma-carboxylation, transport, and amino-terminal cleavage of proteins
R-HSA-190861;Gap junction assembly
R-HSA-190873;Gap junction degradation
R-HSA-190828;Gap junction trafficking
R-HSA-157858;Gap junction trafficking and regulation
R-HSA-5696397;Gap-filling DNA repair synthesis and ligation in GG-NER
R-HSA-6782210;Gap-filling DNA repair synthesis and ligation in TC-NER
R-HSA-881907;Gastrin-CREB signalling pathway via PKC and MAPK
R-HSA-211000;Gene Silencing by RNA
R-HSA-8950505;Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
R-HSA-74160;Gene expression (Transcription)
R-HSA-202433;Generation of second messenger molecules
R-HSA-212436;Generic Transcription Pathway
R-HSA-5696399;Global Genome Nucleotide Excision Repair (GG-NER)
R-HSA-163359;Glucagon signaling in metabolic regulation
R-HSA-381676;Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
R-HSA-420092;Glucagon-type ligand receptors
R-HSA-194002;Glucocorticoid biosynthesis
R-HSA-70263;Gluconeogenesis
R-HSA-70326;Glucose metabolism
R-HSA-156588;Glucuronidation
R-HSA-210500;Glutamate Neurotransmitter Release Cycle
R-HSA-399721;Glutamate binding, activation of AMPA receptors and synaptic plasticity
R-HSA-156590;Glutathione conjugation
R-HSA-174403;Glutathione synthesis and recycling
R-HSA-1483206;Glycerophospholipid biosynthesis
R-HSA-6814848;Glycerophospholipid catabolism
R-HSA-6783984;Glycine degradation
R-HSA-70221;Glycogen breakdown (glycogenolysis)
R-HSA-8982491;Glycogen metabolism
R-HSA-3858516;Glycogen storage disease type 0 (liver GYS2)
R-HSA-3828062;Glycogen storage disease type 0 (muscle GYS1)
R-HSA-5357609;Glycogen storage disease type II (GAA)
R-HSA-3878781;Glycogen storage disease type IV (GBE1)
R-HSA-3274531;Glycogen storage disease type Ia (G6PC)
R-HSA-3229133;Glycogen storage disease type Ib (SLC37A4)
R-HSA-3814836;Glycogen storage disease type XV (GYG1)
R-HSA-3229121;Glycogen storage diseases
R-HSA-3322077;Glycogen synthesis
R-HSA-70171;Glycolysis
R-HSA-209822;Glycoprotein hormones
R-HSA-1630316;Glycosaminoglycan metabolism
R-HSA-1660662;Glycosphingolipid metabolism
R-HSA-389661;Glyoxylate metabolism and glycine degradation
R-HSA-432722;Golgi Associated Vesicle Biogenesis
R-HSA-162658;Golgi Cisternae Pericentriolar Stack Reorganization
R-HSA-8856688;Golgi-to-ER retrograde transport
R-HSA-982772;Growth hormone receptor signaling
R-HSA-3214847;HATs acetylate histones
R-HSA-1296061;HCN channels
R-HSA-3214815;HDACs deacetylate histones
R-HSA-8963896;HDL assembly
R-HSA-8964011;HDL clearance
R-HSA-8964058;HDL remodeling
R-HSA-3214842;HDMs demethylate histones
R-HSA-5693567;HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)
R-HSA-5685942;HDR through Homologous Recombination (HRR)
R-HSA-5685939;HDR through MMEJ (alt-NHEJ)
R-HSA-5685938;HDR through Single Strand Annealing (SSA)
R-HSA-5658034;HHAT G278V abrogates palmitoylation of Hh-Np
R-HSA-162906;HIV Infection
R-HSA-162587;HIV Life Cycle
R-HSA-167169;HIV Transcription Elongation
R-HSA-167161;HIV Transcription Initiation
R-HSA-167287;HIV elongation arrest and recovery
R-HSA-2022928;HS-GAG biosynthesis
R-HSA-2024096;HS-GAG degradation
R-HSA-3371511;HSF1 activation
R-HSA-3371571;HSF1-dependent transactivation
R-HSA-3371497;HSP90 chaperone cycle for steroid hormone receptors (SHR)
R-HSA-5610787;Hedgehog 'off' state
R-HSA-5632684;Hedgehog 'on' state
R-HSA-5358346;Hedgehog ligand biogenesis
R-HSA-189451;Heme biosynthesis
R-HSA-189483;Heme degradation
R-HSA-109582;Hemostasis
R-HSA-1638091;Heparan sulfate/heparin (HS-GAG) metabolism
R-HSA-5657560;Hereditary fructose intolerance
R-HSA-5387390;Hh mutants abrogate ligand secretion
R-HSA-5362768;Hh mutants that don't undergo autocatalytic processing are degraded by ERAD
R-HSA-629597;Highly calcium permeable nicotinic acetylcholine receptors
R-HSA-629594;Highly calcium permeable postsynaptic nicotinic acetylcholine receptors
R-HSA-629587;Highly sodium permeable acetylcholine nicotinic receptors
R-HSA-390650;Histamine receptors
R-HSA-70921;Histidine catabolism
R-HSA-6788656;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism
R-HSA-5693579;Homologous DNA Pairing and Strand Exchange
R-HSA-5693538;Homology Directed Repair
R-HSA-375281;Hormone ligand-binding receptors
R-HSA-162909;Host Interactions of HIV factors
R-HSA-168253;Host Interactions with Influenza Factors
R-HSA-450520;HuR (ELAVL1) binds and stabilizes mRNA
R-HSA-2142850;Hyaluronan biosynthesis and export
R-HSA-2142845;Hyaluronan metabolism
R-HSA-2160916;Hyaluronan uptake and degradation
R-HSA-1483115;Hydrolysis of LPC
R-HSA-1483152;Hydrolysis of LPE
R-HSA-3296197;Hydroxycarboxylic acid-binding receptors
R-HSA-204626;Hypusine synthesis from eIF5A-lysine
R-HSA-2428924;IGF1R signaling cascade
R-HSA-5602636;IKBKB deficiency causes SCID
R-HSA-5603027;IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)
R-HSA-937041;IKK complex recruitment mediated by RIP1
R-HSA-6788467;IL-6-type cytokine receptor ligand interactions
R-HSA-1855196;IP3 and IP4 transport between cytosol and nucleus
R-HSA-1855229;IP6 and IP7 transport between cytosol and nucleus
R-HSA-1855215;IPs transport between ER lumen and cytosol
R-HSA-1855156;IPs transport between ER lumen and nucleus
R-HSA-1855184;IPs transport between cytosol and ER lumen
R-HSA-1855192;IPs transport between nucleus and ER lumen
R-HSA-1855170;IPs transport between nucleus and cytosol
R-HSA-937039;IRAK1 recruits IKK complex
R-HSA-975144;IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation
R-HSA-937042;IRAK2 mediated activation of TAK1 complex
R-HSA-975163;IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
R-HSA-5603041;IRAK4 deficiency (TLR2/4)
R-HSA-5603037;IRAK4 deficiency (TLR5)
R-HSA-381070;IRE1alpha activates chaperones
R-HSA-1606341;IRF3 mediated activation of type 1 IFN
R-HSA-3270619;IRF3-mediated induction of type I IFN
R-HSA-74713;IRS activation
R-HSA-112399;IRS-mediated signalling
R-HSA-2428928;IRS-related events triggered by IGF1R
R-HSA-1169408;ISG15 antiviral mechanism
R-HSA-5603029;IkBA variant leads to EDA-ID
R-HSA-168256;Immune System
R-HSA-198933;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
R-HSA-200425;Import of palmitoyl-CoA into the mitochondrial matrix
R-HSA-141430;Inactivation of APC/C via direct inhibition of the APC/C complex
R-HSA-428543;Inactivation of CDC42 and RAC1
R-HSA-2514859;Inactivation, recovery and regulation of the phototransduction cascade
R-HSA-400508;Incretin synthesis, secretion, and inactivation
R-HSA-5663205;Infectious disease
R-HSA-622312;Inflammasomes
R-HSA-168254;Influenza Infection
R-HSA-168255;Influenza Life Cycle
R-HSA-168273;Influenza Viral RNA Transcription and Replication
R-HSA-168277;Influenza Virus Induced Apoptosis
R-HSA-997272;Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits
R-HSA-168315;Inhibition of Host mRNA Processing and RNA Silencing
R-HSA-168888;Inhibition of IFN-beta
R-HSA-168305;Inhibition of Interferon Synthesis
R-HSA-169131;Inhibition of PKR
R-HSA-5638303;Inhibition of Signaling by Overexpressed EGFR
R-HSA-165181;Inhibition of TSC complex formation by PKB
R-HSA-997269;Inhibition of adenylate cyclase pathway
R-HSA-113501;Inhibition of replication initiation of damaged DNA by RB1/E2F1
R-HSA-141405;Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
R-HSA-166663;Initial triggering of complement
R-HSA-2995383;Initiation of Nuclear Envelope Reformation
R-HSA-8876493;InlA-mediated entry of Listeria monocytogenes into host cells
R-HSA-8875360;InlB-mediated entry of Listeria monocytogenes into host cell
R-HSA-168249;Innate Immune System
R-HSA-1483249;Inositol phosphate metabolism
R-HSA-429593;Inositol transporters
R-HSA-163754;Insulin effects increased synthesis of Xylulose-5-Phosphate
R-HSA-264876;Insulin processing
R-HSA-77387;Insulin receptor recycling
R-HSA-74751;Insulin receptor signalling cascade
R-HSA-428359;Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA
R-HSA-163685;Integration of energy metabolism
R-HSA-162592;Integration of provirus
R-HSA-175567;Integration of viral DNA into host genomic DNA
R-HSA-354192;Integrin alphaIIb beta3 signaling
R-HSA-216083;Integrin cell surface interactions
R-HSA-9006921;Integrin signaling
R-HSA-2534343;Interaction With Cumulus Cells
R-HSA-1300644;Interaction With The Zona Pellucida
R-HSA-445095;Interaction between L1 and Ankyrins
R-HSA-8854521;Interaction between PHLDA1 and AURKA
R-HSA-177243;Interactions of Rev with host cellular proteins
R-HSA-176034;Interactions of Tat with host cellular proteins
R-HSA-176033;Interactions of Vpr with host cellular proteins
R-HSA-880009;Interconversion of 2-oxoglutarate and 2-hydroxyglutarate
R-HSA-499943;Interconversion of nucleotide di- and triphosphates
R-HSA-351200;Interconversion of polyamines
R-HSA-913531;Interferon Signaling
R-HSA-909733;Interferon alpha/beta signaling
R-HSA-877300;Interferon gamma signaling
R-HSA-912526;Interleukin receptor SHC signaling
R-HSA-446652;Interleukin-1 family signaling
R-HSA-448706;Interleukin-1 processing
R-HSA-6783783;Interleukin-10 signaling
R-HSA-447115;Interleukin-12 family signaling
R-HSA-8983432;Interleukin-15 signaling
R-HSA-448424;Interleukin-17 signaling
R-HSA-9012546;Interleukin-18 signaling
R-HSA-451927;Interleukin-2 family signaling
R-HSA-8854691;Interleukin-20 family signaling
R-HSA-512988;Interleukin-3, 5 and GM-CSF signaling
R-HSA-9014843;Interleukin-33 signaling
R-HSA-8984722;Interleukin-35 Signalling
R-HSA-9014826;Interleukin-36 pathway
R-HSA-9008059;Interleukin-37 signaling
R-HSA-9007892;Interleukin-38 signaling
R-HSA-6785807;Interleukin-4 and 13 signaling
R-HSA-6783589;Interleukin-6 family signaling
R-HSA-1266695;Interleukin-7 signaling
R-HSA-8985947;Interleukin-9 signaling
R-HSA-8963676;Intestinal absorption
R-HSA-8981373;Intestinal hexose absorption
R-HSA-8942233;Intestinal infectious diseases
R-HSA-8963678;Intestinal lipid absorption
R-HSA-5659898;Intestinal saccharidase deficiencies
R-HSA-6811442;Intra-Golgi and retrograde Golgi-to-ER traffic
R-HSA-6811438;Intra-Golgi traffic
R-HSA-8981607;Intracellular oxygen transport
R-HSA-9006925;Intracellular signaling by second messengers
R-HSA-5620924;Intraflagellar transport
R-HSA-109606;Intrinsic Pathway for Apoptosis
R-HSA-140837;Intrinsic Pathway of Fibrin Clot Formation
R-HSA-8941237;Invadopodia formation
R-HSA-1296065;Inwardly rectifying K+ channels
R-HSA-983712;Ion channel transport
R-HSA-5578775;Ion homeostasis
R-HSA-6803544;Ion influx/efflux at host-pathogen interface
R-HSA-936837;Ion transport by P-type ATPases
R-HSA-451306;Ionotropic activity of kainate receptors
R-HSA-917937;Iron uptake and transport
R-HSA-450321;JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1
R-HSA-5689877;Josephin domain DUBs
R-HSA-450604;KSRP (KHSRP) binds and destabilizes mRNA
R-HSA-2022854;Keratan sulfate biosynthesis
R-HSA-2022857;Keratan sulfate degradation
R-HSA-1638074;Keratan sulfate/keratin metabolism
R-HSA-6805567;Keratinization
R-HSA-74182;Ketone body metabolism
R-HSA-983189;Kinesins
R-HSA-156827;L13a-mediated translational silencing of Ceruloplasmin expression
R-HSA-373760;L1CAM interactions
R-HSA-8964038;LDL clearance
R-HSA-8964041;LDL remodeling
R-HSA-5682910;LGI-ADAM interactions
R-HSA-3134973;LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
R-HSA-5653890;Lactose synthesis
R-HSA-69186;Lagging Strand Synthesis
R-HSA-3000157;Laminin interactions
R-HSA-162599;Late Phase of HIV Life Cycle
R-HSA-1222352;Latent infection of Homo sapiens with Mycobacterium tuberculosis
R-HSA-69109;Leading Strand Synthesis
R-HSA-166662;Lectin pathway of complement activation
R-HSA-391906;Leukotriene receptors
R-HSA-140534;Ligand-dependent caspase activation
R-HSA-418889;Ligand-independent caspase activation via DCC
R-HSA-5632681;Ligand-receptor interactions
R-HSA-2046105;Linoleic acid (LA) metabolism
R-HSA-8964572;Lipid particle organization
R-HSA-8876384;Listeria monocytogenes entry into host cells
R-HSA-446343;Localization of the PINCH-ILK-PARVIN complex to focal adhesions
R-HSA-2644607;Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling
R-HSA-3304349;Loss of Function of SMAD2/3 in Cancer
R-HSA-3304347;Loss of Function of SMAD4 in Cancer
R-HSA-3656534;Loss of Function of TGFBR1 in Cancer
R-HSA-3642278;Loss of Function of TGFBR2 in Cancer
R-HSA-380259;Loss of Nlp from mitotic centrosomes
R-HSA-380284;Loss of proteins required for interphase microtubule organization from the centrosome
R-HSA-71064;Lysine catabolism
R-HSA-5357572;Lysosomal glycogen catabolism
R-HSA-8853383;Lysosomal oligosaccharide catabolism
R-HSA-432720;Lysosome Vesicle Biogenesis
R-HSA-419408;Lysosphingolipid and LPA receptors
R-HSA-68886;M Phase
R-HSA-68874;M/G1 Transition
R-HSA-450294;MAP kinase activation in TLR cascade
R-HSA-5674135;MAP2K and MAPK activation
R-HSA-5684264;MAP3K8 (TPL2)-dependent MAPK1/3 activation
R-HSA-5683057;MAPK family signaling cascades
R-HSA-450282;MAPK targets/ Nuclear events mediated by MAP kinases
R-HSA-112411;MAPK1 (ERK2) activation
R-HSA-5684996;MAPK1/MAPK3 signaling
R-HSA-110056;MAPK3 (ERK1) activation
R-HSA-5687128;MAPK6/MAPK4 signaling
R-HSA-2465910;MASTL Facilitates Mitotic Progression
R-HSA-6806942;MET Receptor Activation
R-HSA-8851907;MET activates PI3K/AKT signaling
R-HSA-8874081;MET activates PTK2 signaling
R-HSA-8865999;MET activates PTPN11
R-HSA-8875555;MET activates RAP1 and RAC1
R-HSA-8851805;MET activates RAS signaling
R-HSA-8875791;MET activates STAT3
R-HSA-8875513;MET interacts with TNS proteins
R-HSA-8875878;MET promotes cell motility
R-HSA-8875656;MET receptor recycling
R-HSA-5657655;MGMT-mediated DNA damage reversal
R-HSA-2132295;MHC class II antigen presentation
R-HSA-2206302;MPS I - Hurler syndrome
R-HSA-2206296;MPS II - Hunter syndrome
R-HSA-2206307;MPS IIIA - Sanfilippo syndrome A
R-HSA-2206282;MPS IIIB - Sanfilippo syndrome B
R-HSA-2206291;MPS IIIC - Sanfilippo syndrome C
R-HSA-2206305;MPS IIID - Sanfilippo syndrome D
R-HSA-2206290;MPS IV - Morquio syndrome A
R-HSA-2206308;MPS IV - Morquio syndrome B
R-HSA-2206280;MPS IX - Natowicz syndrome
R-HSA-2206285;MPS VI - Maroteaux-Lamy syndrome
R-HSA-2206292;MPS VII - Sly syndrome
R-HSA-5660489;MTF1 activates gene expression
R-HSA-1632852;Macroautophagy
R-HSA-6791226;Major pathway of rRNA processing in the nucleolus and cytosol
R-HSA-1500620;Meiosis
R-HSA-912446;Meiotic recombination
R-HSA-1221632;Meiotic synapsis
R-HSA-5662702;Melanin biosynthesis
R-HSA-199991;Membrane Trafficking
R-HSA-174490;Membrane binding and targetting of GAG proteins
R-HSA-5579029;Metabolic disorders of biological oxidation enzymes
R-HSA-1430728;Metabolism
R-HSA-2022377;Metabolism of Angiotensinogen to Angiotensins
R-HSA-8953854;Metabolism of RNA
R-HSA-71291;Metabolism of amino acids and derivatives
R-HSA-71387;Metabolism of carbohydrates
R-HSA-8978934;Metabolism of cofactors
R-HSA-6806667;Metabolism of fat-soluble vitamins
R-HSA-196757;Metabolism of folate and pterines
R-HSA-2408550;Metabolism of ingested H2SeO4 and H2SeO3 into H2Se
R-HSA-5263617;Metabolism of ingested MeSeO2H into MeSeH
R-HSA-2408508;Metabolism of ingested SeMet, Sec, MeSec into H2Se
R-HSA-556833;Metabolism of lipids
R-HSA-202131;Metabolism of nitric oxide
R-HSA-194441;Metabolism of non-coding RNA
R-HSA-15869;Metabolism of nucleotides
R-HSA-351202;Metabolism of polyamines
R-HSA-189445;Metabolism of porphyrins
R-HSA-392499;Metabolism of proteins
R-HSA-380612;Metabolism of serotonin
R-HSA-196071;Metabolism of steroid hormones
R-HSA-8957322;Metabolism of steroids
R-HSA-6806664;Metabolism of vitamin K
R-HSA-196854;Metabolism of vitamins and cofactors
R-HSA-196849;Metabolism of water-soluble vitamins and cofactors
R-HSA-425410;Metal ion SLC transporters
R-HSA-6799990;Metal sequestration by antimicrobial proteins
R-HSA-5689901;Metalloprotease DUBs
R-HSA-5661231;Metallothioneins bind metals
R-HSA-1237112;Methionine salvage pathway
R-HSA-156581;Methylation
R-HSA-2408552;Methylation of MeSeH for excretion
R-HSA-203927;MicroRNA (miRNA) biogenesis
R-HSA-190840;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
R-HSA-193993;Mineralocorticoid biosynthesis
R-HSA-164516;Minus-strand DNA synthesis
R-HSA-211958;Miscellaneous substrates
R-HSA-5223345;Miscellaneous transport and binding events
R-HSA-5358508;Mismatch Repair
R-HSA-5358606;Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
R-HSA-5358565;Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
R-HSA-5339716;Misspliced GSK3beta mutants stabilize beta-catenin
R-HSA-5339717;Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
R-HSA-1369007;Mitochondrial ABC transporters
R-HSA-77289;Mitochondrial Fatty Acid Beta-Oxidation
R-HSA-166187;Mitochondrial Uncoupling Proteins
R-HSA-1592230;Mitochondrial biogenesis
R-HSA-8949215;Mitochondrial calcium ion transport
R-HSA-1362409;Mitochondrial iron-sulfur cluster biogenesis
R-HSA-1268020;Mitochondrial protein import
R-HSA-379726;Mitochondrial tRNA aminoacylation
R-HSA-163282;Mitochondrial transcription initiation
R-HSA-163316;Mitochondrial transcription termination
R-HSA-5368287;Mitochondrial translation
R-HSA-5389840;Mitochondrial translation elongation
R-HSA-5368286;Mitochondrial translation initiation
R-HSA-5419276;Mitochondrial translation termination
R-HSA-5205647;Mitophagy
R-HSA-68882;Mitotic Anaphase
R-HSA-453279;Mitotic G1-G1/S phases
R-HSA-453274;Mitotic G2-G2/M phases
R-HSA-2555396;Mitotic Metaphase and Anaphase
R-HSA-68881;Mitotic Metaphase/Anaphase Transition
R-HSA-68877;Mitotic Prometaphase
R-HSA-68875;Mitotic Prophase
R-HSA-69618;Mitotic Spindle Checkpoint
R-HSA-68884;Mitotic Telophase/Cytokinesis
R-HSA-2129379;Molecules associated with elastic fibres
R-HSA-947581;Molybdenum cofactor biosynthesis
R-HSA-1222449;Mtb iron assimilation by chelation
R-HSA-2206281;Mucopolysaccharidoses
R-HSA-427601;Multifunctional anion exchangers
R-HSA-390648;Muscarinic acetylcholine receptors
R-HSA-397014;Muscle contraction
R-HSA-975871;MyD88 cascade initiated on plasma membrane
R-HSA-5602498;MyD88 deficiency (TLR2/4)
R-HSA-5602680;MyD88 deficiency (TLR5)
R-HSA-975155;MyD88 dependent cascade initiated on endosome
R-HSA-166166;MyD88-independent TLR4 cascade 
R-HSA-166058;MyD88:Mal cascade initiated on plasma membrane
R-HSA-3785653;Myoclonic epilepsy of Lafora
R-HSA-525793;Myogenesis
R-HSA-975577;N-Glycan antennae elongation
R-HSA-975576;N-glycan antennae elongation in the medial/trans-Golgi
R-HSA-964739;N-glycan trimming and elongation in the cis-Golgi
R-HSA-532668;N-glycan trimming in the ER and Calnexin/Calreticulin cycle
R-HSA-205025;NADE modulates death signalling
R-HSA-389542;NADPH regeneration
R-HSA-375165;NCAM signaling for neurite out-growth
R-HSA-419037;NCAM1 interactions
R-HSA-168333;NEP/NS2 Interacts with the Cellular Export Machinery
R-HSA-933543;NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
R-HSA-209560;NF-kB is activated and signals survival
R-HSA-205017;NFG and proNGF binds to p75NTR
R-HSA-167060;NGF processing
R-HSA-187037;NGF signalling via TRKA from the plasma membrane
R-HSA-187024;NGF-independant TRKA activation
R-HSA-5676590;NIK-->noncanonical NF-kB signaling
R-HSA-168638;NOD1/2 Signaling Pathway
R-HSA-203754;NOSIP mediated eNOS trafficking
R-HSA-203641;NOSTRIN mediated eNOS trafficking
R-HSA-2122947;NOTCH1 Intracellular Domain Regulates Transcription
R-HSA-2979096;NOTCH2 Activation and Transmission of Signal to the Nucleus
R-HSA-2197563;NOTCH2 intracellular domain regulates transcription
R-HSA-1368071;NR1D1 (REV-ERBA) represses gene expression
R-HSA-193648;NRAGE signals death through JNK
R-HSA-205043;NRIF signals cell death from the nucleus
R-HSA-442660;Na+/Cl- dependent neurotransmitter transporters
R-HSA-420597;Nectin/Necl  trans heterodimerization
R-HSA-8951664;Neddylation
R-HSA-167590;Nef Mediated CD4 Down-regulation
R-HSA-182218;Nef Mediated CD8 Down-regulation
R-HSA-164944;Nef and signal transduction
R-HSA-164939;Nef mediated downregulation of CD28 cell surface expression
R-HSA-164940;Nef mediated downregulation of MHC class I complex cell surface expression
R-HSA-164938;Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
R-HSA-5250941;Negative epigenetic regulation of rRNA expression
R-HSA-5674499;Negative feedback regulation of MAPK pathway
R-HSA-5654726;Negative regulation of FGFR1 signaling
R-HSA-5654727;Negative regulation of FGFR2 signaling
R-HSA-5654732;Negative regulation of FGFR3 signaling
R-HSA-5654733;Negative regulation of FGFR4 signaling
R-HSA-5675221;Negative regulation of MAPK pathway
R-HSA-6807004;Negative regulation of MET activity
R-HSA-5368598;Negative regulation of TCF-dependent signaling by DVL-interacting proteins
R-HSA-3772470;Negative regulation of TCF-dependent signaling by WNT ligand antagonists
R-HSA-8866904;Negative regulation of activity of TFAP2 (AP-2) family transcription factors
R-HSA-199418;Negative regulation of the PI3K/AKT network
R-HSA-936440;Negative regulators of DDX58/IFIH1 signaling
R-HSA-373753;Nephrin family interactions
R-HSA-418886;Netrin mediated repulsion signals
R-HSA-373752;Netrin-1 signaling
R-HSA-6794361;Neurexins and neuroligins
R-HSA-8863678;Neurodegenerative Diseases
R-HSA-447043;Neurofascin interactions
R-HSA-112316;Neuronal System
R-HSA-194306;Neurophilin interactions with VEGF and VEGFR
R-HSA-168799;Neurotoxicity of clostridium toxins
R-HSA-112311;Neurotransmitter clearance
R-HSA-112314;Neurotransmitter receptors and postsynaptic signal transmission
R-HSA-112310;Neurotransmitter release cycle
R-HSA-112313;Neurotransmitter uptake and metabolism In glial cells
R-HSA-6798695;Neutrophil degranulation
R-HSA-197264;Nicotinamide salvaging
R-HSA-196807;Nicotinate metabolism
R-HSA-392154;Nitric oxide stimulates guanylate cyclase
R-HSA-427413;NoRC negatively regulates rRNA expression
R-HSA-3000171;Non-integrin membrane-ECM interactions
R-HSA-5693571;Nonhomologous End-Joining (NHEJ)
R-HSA-975957;Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
R-HSA-975956;Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
R-HSA-927802;Nonsense-Mediated Decay (NMD)
R-HSA-181430;Norepinephrine Neurotransmitter Release Cycle
R-HSA-350054;Notch-HLH transcription pathway
R-HSA-447038;NrCAM interactions
R-HSA-2980766;Nuclear Envelope Breakdown
R-HSA-2995410;Nuclear Envelope Reassembly
R-HSA-198725;Nuclear Events (kinase and transcription factor activation)
R-HSA-3301854;Nuclear Pore Complex (NPC) Disassembly
R-HSA-383280;Nuclear Receptor transcription pathway
R-HSA-180746;Nuclear import of Rev protein
R-HSA-1251985;Nuclear signaling by ERBB4
R-HSA-8956320;Nucleobase biosynthesis
R-HSA-8956319;Nucleobase catabolism
R-HSA-774815;Nucleosome assembly
R-HSA-5696398;Nucleotide Excision Repair
R-HSA-8956321;Nucleotide salvage
R-HSA-168643;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways
R-HSA-418038;Nucleotide-like (purinergic) receptors
R-HSA-5173214;O-glycosylation of TSR domain-containing proteins
R-HSA-5173105;O-linked glycosylation
R-HSA-913709;O-linked glycosylation of mucins
R-HSA-1480926;O2/CO2 exchange in erythrocytes
R-HSA-381753;Olfactory Signaling Pathway
R-HSA-190704;Oligomerization of connexins into connexons
R-HSA-2559585;Oncogene Induced Senescence
R-HSA-6802957;Oncogenic MAPK signaling
R-HSA-111885;Opioid Signalling
R-HSA-419771;Opsins
R-HSA-68949;Orc1 removal from chromatin
R-HSA-389397;Orexin and neuropeptides FF and QRFP bind to their respective receptors
R-HSA-1852241;Organelle biogenesis and maintenance
R-HSA-561048;Organic anion transport
R-HSA-428643;Organic anion transporters
R-HSA-549127;Organic cation transport
R-HSA-549132;Organic cation/anion/zwitterion transport
R-HSA-449836;Other interleukin signaling
R-HSA-416700;Other semaphorin interactions
R-HSA-5689896;Ovarian tumor domain proteases
R-HSA-2559580;Oxidative Stress Induced Senescence
R-HSA-1234162;Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha
R-HSA-1234176;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
R-HSA-417957;P2Y receptors
R-HSA-141334;PAOs oxidise polyamines to amines
R-HSA-5651801;PCNA-Dependent Long Patch Base Excision Repair
R-HSA-4086400;PCP/CE pathway
R-HSA-389948;PD-1 signaling
R-HSA-165160;PDE3B signalling
R-HSA-210990;PECAM1 interactions
R-HSA-381042;PERK regulates gene expression
R-HSA-1483255;PI Metabolism
R-HSA-1483196;PI and PC transport between ER and Golgi membranes
R-HSA-5654689;PI-3K cascade:FGFR1
R-HSA-5654695;PI-3K cascade:FGFR2
R-HSA-5654710;PI-3K cascade:FGFR3
R-HSA-5654720;PI-3K cascade:FGFR4
R-HSA-109704;PI3K Cascade
R-HSA-1963642;PI3K events in ERBB2 signaling
R-HSA-1250342;PI3K events in ERBB4 signaling
R-HSA-2219528;PI3K/AKT Signaling in Cancer
R-HSA-198203;PI3K/AKT activation
R-HSA-6811555;PI5P Regulates TP53 Acetylation
R-HSA-6811558;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
R-HSA-1257604;PIP3 activates AKT signaling
R-HSA-1660510;PIPs transport between Golgi and plasma membranes
R-HSA-1660502;PIPs transport between early and late endosome membranes
R-HSA-1660537;PIPs transport between early endosome and Golgi membranes
R-HSA-1660508;PIPs transport between late endosome and Golgi membranes
R-HSA-1660524;PIPs transport between plasma and early endosome membranes
R-HSA-5601884;PIWI-interacting RNA (piRNA) biogenesis
R-HSA-163615;PKA activation
R-HSA-164378;PKA activation in glucagon signalling
R-HSA-111931;PKA-mediated phosphorylation of CREB
R-HSA-163358;PKA-mediated phosphorylation of key metabolic factors
R-HSA-109703;PKB-mediated events
R-HSA-3214841;PKMTs methylate histone lysines
R-HSA-112043;PLC beta mediated events
R-HSA-167021;PLC-gamma1 signalling
R-HSA-1251932;PLCG1 events in ERBB2 signaling
R-HSA-110362;POLB-Dependent Long Patch Base Excision Repair
R-HSA-2892247;POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
R-HSA-2892245;POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation
R-HSA-163767;PP2A-mediated dephosphorylation of key metabolic factors
R-HSA-1989781;PPARA activates gene expression
R-HSA-212300;PRC2 methylates histones and DNA
R-HSA-5674404;PTEN Loss of Function in Cancer
R-HSA-6807070;PTEN Regulation
R-HSA-8849474;PTK6 Activates STAT3
R-HSA-8849472;PTK6 Down-Regulation
R-HSA-8849473;PTK6 Expression
R-HSA-8849470;PTK6 Regulates Cell Cycle
R-HSA-8849468;PTK6 Regulates Proteins Involved in RNA Processing
R-HSA-8849471;PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
R-HSA-8849469;PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1
R-HSA-8857538;PTK6 promotes HIF1A stabilization
R-HSA-171306;Packaging Of Telomere Ends
R-HSA-168303;Packaging of Eight RNA Segments
R-HSA-6802955;Paradoxical activation of RAF signaling by kinase inactive BRAF
R-HSA-432047;Passive transport by Aquaporins
R-HSA-167290;Pausing and recovery of HIV elongation
R-HSA-167238;Pausing and recovery of Tat-mediated HIV elongation
R-HSA-71336;Pentose phosphate pathway (hexose monophosphate shunt)
R-HSA-6791465;Pentose phosphate pathway disease
R-HSA-156902;Peptide chain elongation
R-HSA-209952;Peptide hormone biosynthesis
R-HSA-2980736;Peptide hormone metabolism
R-HSA-375276;Peptide ligand-binding receptors
R-HSA-390918;Peroxisomal lipid metabolism
R-HSA-5576892;Phase 0 - rapid depolarisation
R-HSA-5576894;Phase 1 - inactivation of fast Na+ channels
R-HSA-5576893;Phase 2 - plateau phase
R-HSA-5576890;Phase 3 - rapid repolarisation
R-HSA-5576886;Phase 4 - resting membrane potential
R-HSA-211945;Phase I - Functionalization of compounds
R-HSA-156580;Phase II - Conjugation of compounds
R-HSA-71182;Phenylalanine and tyrosine catabolism
R-HSA-2160456;Phenylketonuria
R-HSA-8850843;Phosphate bond hydrolysis by NTPDase proteins
R-HSA-2393930;Phosphate bond hydrolysis by NUDT proteins
R-HSA-5654219;Phospholipase C-mediated cascade: FGFR1
R-HSA-5654221;"Phospholipase C-mediated cascade; FGFR2"
R-HSA-5654227;"Phospholipase C-mediated cascade; FGFR3"
R-HSA-5654228;"Phospholipase C-mediated cascade; FGFR4"
R-HSA-1483257;Phospholipid metabolism
R-HSA-202427;Phosphorylation of CD3 and TCR zeta chains
R-HSA-176417;Phosphorylation of Emi1
R-HSA-69200;Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes
R-HSA-170145;Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
R-HSA-176412;Phosphorylation of the APC/C
R-HSA-5578768;Physiological factors
R-HSA-5205685;Pink/Parkin Mediated Mitophagy
R-HSA-8963898;Plasma lipoprotein assembly
R-HSA-174824;Plasma lipoprotein assembly, remodeling, and clearance
R-HSA-8964043;Plasma lipoprotein clearance
R-HSA-8963899;Plasma lipoprotein remodeling
R-HSA-75896;Plasmalogen biosynthesis
R-HSA-75892;Platelet Adhesion to exposed collagen
R-HSA-76009;Platelet Aggregation (Plug Formation)
R-HSA-76002;Platelet activation, signaling and aggregation
R-HSA-418360;Platelet calcium homeostasis
R-HSA-114608;Platelet degranulation 
R-HSA-418346;Platelet homeostasis
R-HSA-432142;Platelet sensitization by LDL
R-HSA-164525;Plus-strand DNA synthesis
R-HSA-156711;Polo-like kinase mediated events
R-HSA-69091;Polymerase switching
R-HSA-174411;Polymerase switching on the C-strand of the telomere
R-HSA-5250913;Positive epigenetic regulation of rRNA expression
R-HSA-438064;Post NMDA receptor activation events
R-HSA-389977;Post-chaperonin tubulin folding pathway
R-HSA-426496;Post-transcriptional silencing by small RNAs
R-HSA-163125;Post-translational modification: synthesis of GPI-anchored proteins
R-HSA-597592;Post-translational protein modification
R-HSA-8957275;Post-translational protein phosphorylation
R-HSA-622327;Postsynaptic nicotinic acetylcholine receptors
R-HSA-1296071;Potassium Channels
R-HSA-1296067;Potassium transport channels
R-HSA-1912422;Pre-NOTCH Expression and Processing
R-HSA-1912420;Pre-NOTCH Processing in Golgi
R-HSA-1912399;Pre-NOTCH Processing in the Endoplasmic Reticulum
R-HSA-1912408;Pre-NOTCH Transcription and Translation
R-HSA-389957;Prefoldin mediated transfer of substrate  to CCT/TriC
R-HSA-196108;Pregnenolone biosynthesis
R-HSA-112308;Presynaptic depolarization and calcium channel opening
R-HSA-500657;Presynaptic function of Kainate receptors
R-HSA-622323;Presynaptic nicotinic acetylcholine receptors
R-HSA-5693616;Presynaptic phase of homologous DNA pairing and strand exchange
R-HSA-3215018;Processing and activation of SUMO
R-HSA-72203;Processing of Capped Intron-Containing Pre-mRNA
R-HSA-75067;Processing of Capped Intronless Pre-mRNA
R-HSA-5693607;Processing of DNA double-strand break ends
R-HSA-77595;Processing of Intronless Pre-mRNAs
R-HSA-8949664;Processing of SMDT1
R-HSA-174414;Processive synthesis on the C-strand of the telomere
R-HSA-69183;Processive synthesis on the lagging strand
R-HSA-5357801;Programmed Cell Death
R-HSA-964827;Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2
R-HSA-1170546;Prolactin receptor signaling
R-HSA-70688;Proline catabolism
R-HSA-169893;Prolonged ERK activation events
R-HSA-71032;Propionyl-CoA catabolism
R-HSA-392851;Prostacyclin signalling through prostacyclin receptor
R-HSA-391908;Prostanoid ligand receptors
R-HSA-391251;Protein folding
R-HSA-8876725;Protein methylation
R-HSA-5676934;Protein repair
R-HSA-8852135;Protein ubiquitination
R-HSA-6794362;Protein-protein interactions at synapses
R-HSA-433692;Proton-coupled monocarboxylate transport
R-HSA-428559;Proton-coupled neutral amino acid transporters
R-HSA-427975;Proton/oligopeptide cotransporters
R-HSA-74259;Purine catabolism
R-HSA-73817;Purine ribonucleoside monophosphate biosynthesis
R-HSA-74217;Purine salvage
R-HSA-500753;Pyrimidine biosynthesis
R-HSA-73621;Pyrimidine catabolism
R-HSA-73614;Pyrimidine salvage
R-HSA-71737;Pyrophosphate hydrolysis
R-HSA-70268;Pyruvate metabolism
R-HSA-71406;Pyruvate metabolism and Citric Acid (TCA) cycle
R-HSA-5365859;RA biosynthesis pathway
R-HSA-8876198;RAB GEFs exchange GTP for GDP on RABs
R-HSA-8873719;RAB geranylgeranylation
R-HSA-5673000;RAF activation
R-HSA-112409;RAF-independent MAPK1/3 activation
R-HSA-5673001;RAF/MAP kinase cascade
R-HSA-6802953;RAS signaling downstream of NF1 loss-of-function variants
R-HSA-8853659;RET signaling
R-HSA-195258;RHO GTPase Effectors
R-HSA-5663220;RHO GTPases Activate Formins
R-HSA-5668599;RHO GTPases Activate NADPH Oxidases
R-HSA-5627117;RHO GTPases Activate ROCKs
R-HSA-5666185;RHO GTPases Activate Rhotekin and Rhophilins
R-HSA-5663213;RHO GTPases Activate WASPs and WAVEs
R-HSA-5625900;RHO GTPases activate CIT
R-HSA-5626467;RHO GTPases activate IQGAPs
R-HSA-5625970;RHO GTPases activate KTN1
R-HSA-5627123;RHO GTPases activate PAKs
R-HSA-5625740;RHO GTPases activate PKNs
R-HSA-5627083;RHO GTPases regulate CFTR trafficking
R-HSA-1810476;RIP-mediated NFkB activation via ZBP1
R-HSA-5213460;RIPK1-mediated regulated necrosis
R-HSA-3214858;RMTs methylate histone arginines
R-HSA-77075;RNA Pol II CTD phosphorylation and interaction with CE
R-HSA-167160;RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
R-HSA-73777;RNA Polymerase I Chain Elongation
R-HSA-73854;RNA Polymerase I Promoter Clearance
R-HSA-73772;RNA Polymerase I Promoter Escape
R-HSA-73728;RNA Polymerase I Promoter Opening
R-HSA-73864;RNA Polymerase I Transcription
R-HSA-73762;RNA Polymerase I Transcription Initiation
R-HSA-73863;RNA Polymerase I Transcription Termination
R-HSA-167162;RNA Polymerase II HIV Promoter Escape
R-HSA-674695;RNA Polymerase II Pre-transcription Events
R-HSA-73776;RNA Polymerase II Promoter Escape
R-HSA-73857;RNA Polymerase II Transcription
R-HSA-75955;RNA Polymerase II Transcription Elongation
R-HSA-75953;RNA Polymerase II Transcription Initiation
R-HSA-76042;RNA Polymerase II Transcription Initiation And Promoter Clearance
R-HSA-73779;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
R-HSA-73856;RNA Polymerase II Transcription Termination
R-HSA-749476;RNA Polymerase III Abortive And Retractive Initiation
R-HSA-73780;RNA Polymerase III Chain Elongation
R-HSA-74158;RNA Polymerase III Transcription
R-HSA-76046;RNA Polymerase III Transcription Initiation
R-HSA-76061;RNA Polymerase III Transcription Initiation From Type 1 Promoter
R-HSA-76066;RNA Polymerase III Transcription Initiation From Type 2 Promoter
R-HSA-76071;RNA Polymerase III Transcription Initiation From Type 3 Promoter
R-HSA-73980;RNA Polymerase III Transcription Termination
R-HSA-6807505;RNA polymerase II transcribes snRNA genes
R-HSA-5340588;RNF mutants show enhanced WNT signaling and proliferation
R-HSA-9010642;ROBO receptors bind AKAP5
R-HSA-1368082;RORA activates gene expression
R-HSA-1222556;ROS, RNS production in phagocytes
R-HSA-5659996;RPIA deficiency: failed conversion of R5P to RU5P
R-HSA-6791461;RPIA deficiency: failed conversion of RU5P to R5P
R-HSA-444257;RSK activation
R-HSA-8877330;RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs)
R-HSA-8939243;RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
R-HSA-8931987;RUNX1 regulates estrogen receptor mediated transcription
R-HSA-8935964;RUNX1 regulates expression of components of tight junctions
R-HSA-8936459;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
R-HSA-8939245;RUNX1 regulates transcription of genes involved in BCR signaling
R-HSA-8939256;RUNX1 regulates transcription of genes involved in WNT signaling
R-HSA-8939236;RUNX1 regulates transcription of genes involved in differentiation of HSCs
R-HSA-8939242;RUNX1 regulates transcription of genes involved in differentiation of keratinocytes
R-HSA-8939246;RUNX1 regulates transcription of genes involved in differentiation of myeloid cells
R-HSA-8939247;RUNX1 regulates transcription of genes involved in interleukin signaling
R-HSA-8941326;RUNX2 regulates bone development
R-HSA-8941284;RUNX2 regulates chondrocyte maturation
R-HSA-8941332;RUNX2 regulates genes involved in cell migration
R-HSA-8941333;RUNX2 regulates genes involved in differentiation of myeloid cells
R-HSA-8940973;RUNX2 regulates osteoblast differentiation
R-HSA-8949275;RUNX3 Regulates Immune Response and Cell Migration
R-HSA-8952158;RUNX3 regulates BCL2L11 (BIM) transcription
R-HSA-8941855;RUNX3 regulates CDKN1A transcription
R-HSA-8941856;RUNX3 regulates NOTCH signaling
R-HSA-8951911;RUNX3 regulates RUNX1-mediated transcription
R-HSA-8951430;RUNX3 regulates WNT signaling
R-HSA-8951671;RUNX3 regulates YAP1-mediated transcription
R-HSA-8951936;RUNX3 regulates p14-ARF
R-HSA-9007101;Rab regulation of trafficking
R-HSA-392517;Rap1 signalling
R-HSA-442982;Ras activation uopn Ca2+ infux through NMDA receptor
R-HSA-975578;Reactions specific to the complex N-glycan synthesis pathway
R-HSA-975574;Reactions specific to the hybrid N-glycan synthesis pathway
R-HSA-8934903;Receptor Mediated Mitophagy
R-HSA-388844;Receptor-type tyrosine-protein phosphatases
R-HSA-110330;Recognition and association of DNA glycosylase with site containing an affected purine
R-HSA-110328;Recognition and association of DNA glycosylase with site containing an affected pyrimidine
R-HSA-110314;Recognition of DNA damage by PCNA-containing replication complex
R-HSA-5693565;Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
R-HSA-380320;Recruitment of NuMA to mitotic centrosomes
R-HSA-380270;Recruitment of mitotic centrosome proteins and complexes
R-HSA-159418;Recycling of bile acids and salts
R-HSA-72731;Recycling of eIF2:GDP
R-HSA-437239;Recycling pathway of L1
R-HSA-418359;Reduction of cytosolic Ca++ levels
R-HSA-8866376;Reelin signalling pathway
R-HSA-5218859;Regulated Necrosis
R-HSA-193692;Regulated proteolysis of p75NTR
R-HSA-3248023;Regulation by TREX1
R-HSA-3371378;Regulation by c-FLIP
R-HSA-176408;Regulation of APC/C activators between G1/S and early anaphase
R-HSA-169911;Regulation of Apoptosis
R-HSA-977606;Regulation of Complement cascade
R-HSA-69304;Regulation of DNA replication
R-HSA-4641263;Regulation of FZD by ubiquitination
R-HSA-170822;Regulation of Glucokinase by Glucokinase Regulatory Protein
R-HSA-3371453;Regulation of HSF1-mediated heat shock response
R-HSA-1234174;Regulation of Hypoxia-inducible Factor (HIF) by oxygen
R-HSA-912694;Regulation of IFNA signaling
R-HSA-877312;Regulation of IFNG signaling
R-HSA-381426;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
R-HSA-1433559;Regulation of KIT signaling
R-HSA-211728;Regulation of PAK-2p34 activity by PS-GAP/RHG10
R-HSA-2565942;Regulation of PLK1 Activity at G2/M Transition
R-HSA-8943724;Regulation of PTEN gene transcription
R-HSA-8948747;Regulation of PTEN localization
R-HSA-8943723;Regulation of PTEN mRNA translation
R-HSA-8948751;Regulation of PTEN stability and activity
R-HSA-5658442;Regulation of RAS by GAPs
R-HSA-8934593;Regulation of RUNX1 Expression and Activity
R-HSA-8939902;Regulation of RUNX2 expression and activity
R-HSA-8941858;Regulation of RUNX3 expression and activity
R-HSA-5686938;Regulation of TLR by endogenous ligand
R-HSA-5357905;Regulation of TNFR1 signaling
R-HSA-5633007;Regulation of TP53 Activity
R-HSA-6804758;Regulation of TP53 Activity through Acetylation
R-HSA-6804759;Regulation of TP53 Activity through Association with Co-factors
R-HSA-6804760;Regulation of TP53 Activity through Methylation
R-HSA-6804756;Regulation of TP53 Activity through Phosphorylation
R-HSA-6804757;Regulation of TP53 Degradation
R-HSA-6804754;Regulation of TP53 Expression
R-HSA-6806003;Regulation of TP53 Expression and Degradation
R-HSA-2029482;Regulation of actin dynamics for phagocytic cup formation
R-HSA-211733;Regulation of activated PAK-2p34 by proteasome mediated degradation
R-HSA-186712;Regulation of beta-cell development
R-HSA-1655829;Regulation of cholesterol biosynthesis by SREBP (SREBF)
R-HSA-428542;Regulation of commissural axon pathfinding by SLIT and ROBO
R-HSA-8985801;Regulation of cortical dendrite branching
R-HSA-446388;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
R-HSA-9010553;Regulation of expression of SLITs and ROBOs
R-HSA-191650;Regulation of gap junction activity
R-HSA-1234158;Regulation of gene expression by Hypoxia-inducible Factor
R-HSA-210745;Regulation of gene expression in beta cells
R-HSA-210747;Regulation of gene expression in early pancreatic precursor cells
R-HSA-210746;Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
R-HSA-210744;Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
R-HSA-3134975;Regulation of innate immune responses to cytosolic DNA
R-HSA-422356;Regulation of insulin secretion
R-HSA-400206;Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
R-HSA-450531;Regulation of mRNA stability by proteins that bind AU-rich elements
R-HSA-453276;Regulation of mitotic cell cycle
R-HSA-5675482;Regulation of necroptotic cell death
R-HSA-350562;Regulation of ornithine decarboxylase (ODC)
R-HSA-204174;Regulation of pyruvate dehydrogenase (PDH) complex
R-HSA-912631;Regulation of signaling by CBL
R-HSA-1433617;Regulation of signaling by NODAL
R-HSA-350864;Regulation of thyroid hormone activity
R-HSA-444821;Relaxin receptors
R-HSA-168298;Release
R-HSA-5362798;Release of Hh-Np from the secreting cell
R-HSA-111457;Release of apoptotic factors from the mitochondria
R-HSA-159782;Removal of aminoterminal propeptides from gamma-carboxylated proteins
R-HSA-69300;Removal of licensing factors from origins
R-HSA-69166;Removal of the Flap Intermediate
R-HSA-174437;Removal of the Flap Intermediate from the C-strand
R-HSA-4641265;Repression of WNT target genes
R-HSA-1474165;Reproduction
R-HSA-110373;Resolution of AP sites via the multiple-nucleotide patch replacement pathway
R-HSA-110381;Resolution of AP sites via the single-nucleotide replacement pathway
R-HSA-73933;Resolution of Abasic Sites (AP sites)
R-HSA-5693537;Resolution of D-Loop Structures
R-HSA-5693568;Resolution of D-loop Structures through Holliday Junction Intermediates
R-HSA-5693554;Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
R-HSA-2500257;Resolution of Sister Chromatid Cohesion
R-HSA-611105;Respiratory electron transport
R-HSA-163200;Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
R-HSA-1222499;Response of Mtb to phagocytosis
R-HSA-76005;Response to elevated platelet cytosolic Ca2+
R-HSA-5660526;Response to metal ions
R-HSA-2453864;Retinoid cycle disease events
R-HSA-975634;Retinoid metabolism and transport
R-HSA-6809583;Retinoid metabolism disease events
R-HSA-177504;Retrograde neurotrophin signalling
R-HSA-6811440;Retrograde transport at the Trans-Golgi-Network
R-HSA-888593;Reuptake of GABA
R-HSA-165054;Rev-mediated nuclear export of HIV RNA
R-HSA-73943;Reversal of alkylation damage by DNA dioxygenases
R-HSA-162589;Reverse Transcription of HIV RNA
R-HSA-1475029;Reversible hydration of carbon dioxide
R-HSA-444411;Rhesus glycoproteins mediate ammonium transport.
R-HSA-194840;Rho GTPase cycle
R-HSA-72702;Ribosomal scanning and start codon recognition
R-HSA-428890;Role of ABL in ROBO-SLIT signaling
R-HSA-2730905;Role of LAT2/NTAL/LAB on calcium mobilization
R-HSA-2029485;Role of phospholipids in phagocytosis
R-HSA-418890;Role of second messengers in netrin-1 signaling
R-HSA-69242;S Phase
R-HSA-5358747;S33 mutants of beta-catenin aren't phosphorylated
R-HSA-5358749;S37 mutants of beta-catenin aren't phosphorylated
R-HSA-5358751;S45 mutants of beta-catenin aren't phosphorylated
R-HSA-187577;SCF(Skp2)-mediated degradation of p27/p21
R-HSA-174113;SCF-beta-TrCP mediated degradation of Emi1
R-HSA-373756;SDK interactions
R-HSA-399955;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
R-HSA-5654688;SHC-mediated cascade:FGFR1
R-HSA-5654699;SHC-mediated cascade:FGFR2
R-HSA-5654704;SHC-mediated cascade:FGFR3
R-HSA-5654719;SHC-mediated cascade:FGFR4
R-HSA-2428933;SHC-related events triggered by IGF1R
R-HSA-180336;SHC1 events in EGFR signaling
R-HSA-1250196;SHC1 events in ERBB2 signaling
R-HSA-1250347;SHC1 events in ERBB4 signaling
R-HSA-427359;SIRT1 negatively regulates rRNA expression
R-HSA-77588;SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
R-HSA-111367;SLBP independent Processing of Histone Pre-mRNAs
R-HSA-5619102;SLC transporter disorders
R-HSA-425407;SLC-mediated transmembrane transport
R-HSA-8985586;SLIT2:ROBO1 increases RHOA activity
R-HSA-111463;SMAC binds to IAPs 
R-HSA-111469;SMAC-mediated apoptotic response
R-HSA-111464;SMAC-mediated dissociation of IAP:caspase complexes 
R-HSA-3315487;SMAD2/3 MH2 Domain Mutants in Cancer
R-HSA-3304356;SMAD2/3 Phosphorylation Motif Mutants in Cancer
R-HSA-2173796;SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
R-HSA-3311021;SMAD4 MH2 Domain Mutants in Cancer
R-HSA-112412;SOS-mediated signalling
R-HSA-1799339;SRP-dependent cotranslational protein targeting to membrane
R-HSA-3249367;STAT6-mediated induction of chemokines
R-HSA-1834941;STING mediated induction of host immune responses
R-HSA-3108232;SUMO E3 ligases SUMOylate target proteins
R-HSA-3065676;SUMO is conjugated to E1 (UBA2:SAE1)
R-HSA-3065679;SUMO is proteolytically processed
R-HSA-3065678;SUMO is transferred from E1 to E2 (UBE2I, UBC9)
R-HSA-2990846;SUMOylation
R-HSA-3108214;SUMOylation of DNA damage response and repair proteins
R-HSA-4615885;SUMOylation of DNA replication proteins
R-HSA-4570464;SUMOylation of RNA binding proteins
R-HSA-4551638;SUMOylation of chromatin organization proteins
R-HSA-3232118;SUMOylation of transcription factors
R-HSA-3000480;Scavenging by Class A Receptors
R-HSA-3000471;Scavenging by Class B Receptors
R-HSA-3000484;Scavenging by Class F Receptors
R-HSA-3000497;Scavenging by Class H Receptors
R-HSA-2168880;Scavenging of heme from plasma
R-HSA-2408517;SeMet incorporation into proteins
R-HSA-2408522;Selenoamino acid metabolism
R-HSA-2408557;Selenocysteine synthesis
R-HSA-399954;Sema3A PAK dependent Axon repulsion
R-HSA-400685;Sema4D in semaphorin signaling
R-HSA-416572;Sema4D induced cell migration and growth-cone collapse
R-HSA-416550;Sema4D mediated inhibition of cell attachment and migration
R-HSA-373755;Semaphorin interactions
R-HSA-2559582;Senescence-Associated Secretory Phenotype (SASP)
R-HSA-5693548;Sensing of DNA Double Strand Breaks
R-HSA-2467813;Separation of Sister Chromatids
R-HSA-977347;Serine biosynthesis
R-HSA-181429;Serotonin Neurotransmitter Release Cycle
R-HSA-209931;Serotonin and melatonin biosynthesis
R-HSA-380615;Serotonin clearance from the synaptic cleft
R-HSA-390666;Serotonin receptors
R-HSA-3282872;Severe congenital neutropenia type 4 (G6PC3)
R-HSA-4085001;Sialic acid metabolism
R-HSA-162582;Signal Transduction
R-HSA-392518;Signal amplification
R-HSA-74749;Signal attenuation
R-HSA-391160;Signal regulatory protein family interactions
R-HSA-445144;Signal transduction by L1
R-HSA-1502540;Signaling by Activin
R-HSA-201451;Signaling by BMP
R-HSA-6802952;Signaling by BRAF and RAF fusions
R-HSA-177929;Signaling by EGFR
R-HSA-1643713;Signaling by EGFR in Cancer
R-HSA-5637812;Signaling by EGFRvIII in Cancer
R-HSA-1227986;Signaling by ERBB2
R-HSA-1236394;Signaling by ERBB4
R-HSA-190236;Signaling by FGFR
R-HSA-1226099;Signaling by FGFR in disease
R-HSA-5654736;Signaling by FGFR1
R-HSA-1839120;Signaling by FGFR1 amplification mutants
R-HSA-5655302;Signaling by FGFR1 in disease
R-HSA-5654738;Signaling by FGFR2
R-HSA-8851708;Signaling by FGFR2 IIIa TM
R-HSA-2023837;Signaling by FGFR2 amplification mutants
R-HSA-8853333;Signaling by FGFR2 fusions
R-HSA-5655253;Signaling by FGFR2 in disease
R-HSA-5654741;Signaling by FGFR3
R-HSA-8853334;Signaling by FGFR3 fusions in cancer
R-HSA-5655332;Signaling by FGFR3 in disease
R-HSA-8853338;Signaling by FGFR3 point mutants in cancer
R-HSA-5654743;Signaling by FGFR4
R-HSA-5655291;Signaling by FGFR4 in disease
R-HSA-372790;Signaling by GPCR
R-HSA-5358351;Signaling by Hedgehog
R-HSA-2028269;Signaling by Hippo
R-HSA-74752;Signaling by Insulin receptor
R-HSA-449147;Signaling by Interleukins
R-HSA-2586552;Signaling by Leptin
R-HSA-5637815;Signaling by Ligand-Responsive EGFR Variants in Cancer
R-HSA-6806834;Signaling by MET
R-HSA-8852405;Signaling by MST1
R-HSA-1181150;Signaling by NODAL
R-HSA-157118;Signaling by NOTCH
R-HSA-1980143;Signaling by NOTCH1
R-HSA-2691230;Signaling by NOTCH1 HD Domain Mutants in Cancer
R-HSA-2894858;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
R-HSA-2644602;Signaling by NOTCH1 PEST Domain Mutants in Cancer
R-HSA-2644603;Signaling by NOTCH1 in Cancer
R-HSA-2660825;"Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant"
R-HSA-1980145;Signaling by NOTCH2
R-HSA-1980148;Signaling by NOTCH3
R-HSA-1980150;Signaling by NOTCH4
R-HSA-9006927;Signaling by Non-Receptor Tyrosine Kinases
R-HSA-9006931;Signaling by Nuclear Receptors
R-HSA-5638302;Signaling by Overexpressed Wild-Type EGFR in Cancer
R-HSA-186797;Signaling by PDGF
R-HSA-8848021;Signaling by PTK6
R-HSA-6802949;Signaling by RAS mutants
R-HSA-376176;Signaling by ROBO receptors
R-HSA-9006934;Signaling by Receptor Tyrosine Kinases
R-HSA-5362517;Signaling by Retinoic Acid
R-HSA-194315;Signaling by Rho GTPases
R-HSA-1433557;Signaling by SCF-KIT
R-HSA-170834;Signaling by TGF-beta Receptor Complex
R-HSA-3304351;Signaling by TGF-beta Receptor Complex in Cancer
R-HSA-9006936;Signaling by TGF-beta family members
R-HSA-2404192;Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
R-HSA-194138;Signaling by VEGF
R-HSA-195721;Signaling by WNT
R-HSA-4791275;Signaling by WNT in cancer
R-HSA-1839122;Signaling by activated point mutants of FGFR1
R-HSA-1839130;Signaling by activated point mutants of FGFR3
R-HSA-1839117;Signaling by cytosolic FGFR1 fusion mutants
R-HSA-6802948;Signaling by high-kinase activity BRAF mutants
R-HSA-6802946;Signaling by moderate kinase activity BRAF mutants
R-HSA-8853336;Signaling by plasma membrane FGFR1 fusions
R-HSA-983705;Signaling by the B Cell Receptor (BCR)
R-HSA-166520;Signalling by NGF
R-HSA-198765;Signalling to ERK5
R-HSA-187687;Signalling to ERKs
R-HSA-167044;Signalling to RAS
R-HSA-198745;Signalling to STAT3
R-HSA-187706;Signalling to p38 via RIT and RIN
R-HSA-426486;Small interfering RNA (siRNA) biogenesis
R-HSA-445355;Smooth Muscle Contraction
R-HSA-427652;Sodium-coupled phosphate cotransporters
R-HSA-433137;Sodium-coupled sulphate, di- and tri-carboxylate transporters
R-HSA-425561;Sodium/Calcium exchangers
R-HSA-425986;Sodium/Proton exchangers
R-HSA-1300642;Sperm Motility And Taxes
R-HSA-1300652;Sperm:Oocyte Membrane Binding
R-HSA-1660661;Sphingolipid de novo biosynthesis
R-HSA-428157;Sphingolipid metabolism
R-HSA-1295596;Spry regulation of FGF signaling
R-HSA-69541;Stabilization of p53
R-HSA-211994;Sterols are 12-hydroxylated by CYP8B1
R-HSA-211736;Stimulation of the cell death response by PAK-2p34
R-HSA-2672351;Stimuli-sensing channels
R-HSA-390522;Striated Muscle Contraction
R-HSA-1614517;Sulfide oxidation to sulfate
R-HSA-1614635;Sulfur amino acid metabolism
R-HSA-5683826;Surfactant metabolism
R-HSA-69052;Switching of origins to a post-replicative state
R-HSA-8849932;Synaptic adhesion-like molecules
R-HSA-3000170;Syndecan interactions
R-HSA-174495;Synthesis And Processing Of GAG, GAGPOL Polyproteins
R-HSA-171286;Synthesis and processing of ENV and VPU
R-HSA-2142816;Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)
R-HSA-2142712;Synthesis of 12-eicosatetraenoic acid derivatives
R-HSA-2142770;Synthesis of 15-eicosatetraenoic acid derivatives
R-HSA-2142688;Synthesis of 5-eicosatetraenoic acids
R-HSA-1483171;Synthesis of BMP
R-HSA-1483076;Synthesis of CL
R-HSA-69239;Synthesis of DNA
R-HSA-446199;Synthesis of Dolichyl-phosphate
R-HSA-446205;Synthesis of GDP-mannose
R-HSA-2142696;Synthesis of Hepoxilins (HX) and Trioxilins (TrX)
R-HSA-1855183;Synthesis of IP2, IP, and Ins in the cytosol
R-HSA-1855204;Synthesis of IP3 and IP4 in the cytosol
R-HSA-1855231;Synthesis of IPs in the ER lumen
R-HSA-1855191;Synthesis of IPs in the nucleus
R-HSA-77111;Synthesis of Ketone Bodies
R-HSA-2142691;Synthesis of Leukotrienes (LT) and Eoxins (EX)
R-HSA-2142700;Synthesis of Lipoxins (LX)
R-HSA-1483166;Synthesis of PA
R-HSA-1483191;Synthesis of PC
R-HSA-1483213;Synthesis of PE
R-HSA-1483148;Synthesis of PG
R-HSA-1483226;Synthesis of PI
R-HSA-1483248;Synthesis of PIPs at the ER membrane
R-HSA-1660514;Synthesis of PIPs at the Golgi membrane
R-HSA-1660516;Synthesis of PIPs at the early endosome membrane
R-HSA-1660517;Synthesis of PIPs at the late endosome membrane
R-HSA-1660499;Synthesis of PIPs at the plasma membrane
R-HSA-8847453;Synthesis of PIPs in the nucleus
R-HSA-1483101;Synthesis of PS
R-HSA-2162123;Synthesis of Prostaglandins (PG) and Thromboxanes (TX)
R-HSA-446210;Synthesis of UDP-N-acetyl-glucosamine
R-HSA-8866652;Synthesis of active ubiquitin: roles of E1 and E2 enzymes
R-HSA-192105;Synthesis of bile acids and bile salts
R-HSA-193775;Synthesis of bile acids and bile salts via 24-hydroxycholesterol
R-HSA-193807;Synthesis of bile acids and bile salts via 27-hydroxycholesterol
R-HSA-193368;Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
R-HSA-5358493;Synthesis of diphthamide-EEF2
R-HSA-162699;Synthesis of dolichyl-phosphate mannose
R-HSA-480985;Synthesis of dolichyl-phosphate-glucose
R-HSA-2142670;Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)
R-HSA-162710;Synthesis of glycosylphosphatidylinositol (GPI)
R-HSA-1855167;Synthesis of pyrophosphates in the cytosol
R-HSA-446219;Synthesis of substrates in N-glycan biosythesis
R-HSA-75876;Synthesis of very long-chain fatty acyl-CoAs
R-HSA-6782861;Synthesis of wybutosine at G37 of tRNA(Phe)
R-HSA-422085;Synthesis, secretion, and deacylation of Ghrelin
R-HSA-381771;Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
R-HSA-400511;Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)
R-HSA-5358752;T41 mutants of beta-catenin aren't phosphorylated
R-HSA-445989;TAK1 activates NFkB by phosphorylation and activation of IKKs complex
R-HSA-6791462;TALDO1 deficiency: failed conversion of  Fru(6)P, E4P to SH7P, GA3P
R-HSA-6791055;TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P
R-HSA-8854214;TBC/RABGAPs
R-HSA-201681;TCF dependent signaling in response to WNT
R-HSA-5339700;TCF7L2 mutants don't bind CTBP
R-HSA-202403;TCR signaling
R-HSA-5221030;TET1,2,3 and TDG demethylate DNA
R-HSA-8866911;TFAP2 (AP-2) family regulates transcription of cell cycle factors
R-HSA-8866910;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
R-HSA-8866906;TFAP2 (AP-2) family regulates transcription of other transcription factors
R-HSA-8869496;TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation
R-HSA-2173789;TGF-beta receptor signaling activates SMADs
R-HSA-2173791;TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
R-HSA-3656532;TGFBR1 KD Mutants in Cancer
R-HSA-3656535;TGFBR1 LBD Mutants in Cancer
R-HSA-3645790;TGFBR2 Kinase Domain Mutants in Cancer
R-HSA-3642279;TGFBR2 MSI Frameshift Mutants in Cancer
R-HSA-5602566;TICAM1 deficiency - HSE
R-HSA-168927;TICAM1, RIP1-mediated IKK complex recruitment 
R-HSA-9014325;TICAM1,TRAF6-dependent induction of TAK1 complex
R-HSA-9013973;TICAM1-dependent activation of IRF3/IRF7
R-HSA-5602410;TLR3 deficiency - HSE
R-HSA-9013957;TLR3-mediated TICAM1-dependent programmed cell death
R-HSA-5676594;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
R-HSA-75893;TNF signaling
R-HSA-5357956;TNFR1-induced NFkappaB signaling pathway
R-HSA-5357786;TNFR1-induced proapoptotic signaling
R-HSA-5626978;TNFR1-mediated ceramide production
R-HSA-5668541;TNFR2 non-canonical NF-kB pathway
R-HSA-5669034;TNFs bind their physiological receptors
R-HSA-5628897;TP53 Regulates Metabolic Genes
R-HSA-6803207;TP53 Regulates Transcription of Caspase Activators and Caspases
R-HSA-6791312;TP53 Regulates Transcription of Cell Cycle Genes
R-HSA-5633008;TP53 Regulates Transcription of Cell Death Genes
R-HSA-6796648;TP53 Regulates Transcription of DNA Repair Genes
R-HSA-6803211;TP53 Regulates Transcription of Death Receptors and Ligands
R-HSA-6803204;TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
R-HSA-6804116;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
R-HSA-6804114;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
R-HSA-6804115;TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
R-HSA-6803205;TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
R-HSA-5602571;TRAF3 deficiency - HSE
R-HSA-918233;TRAF3-dependent IRF activation pathway
R-HSA-933541;TRAF6 mediated IRF7 activation
R-HSA-975110;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling
R-HSA-933542;TRAF6 mediated NF-kB activation
R-HSA-975138;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
R-HSA-937072;TRAF6-mediated induction of TAK1 complex within TLR4 complex
R-HSA-75158;TRAIL  signaling
R-HSA-937061;TRIF(TICAM1)-mediated TLR4 signaling 
R-HSA-2562578;TRIF-mediated programmed cell death
R-HSA-187042;TRKA activation by NGF
R-HSA-3295583;TRP channels
R-HSA-1299503;TWIK related potassium channel (TREK)
R-HSA-1299361;TWIK-related alkaline pH activated K+ channel (TALK)
R-HSA-1299344;TWIK-related spinal cord K+ channel (TRESK)
R-HSA-1299316;TWIK-releated acid-sensitive K+ channel (TASK)
R-HSA-380095;Tachykinin receptors bind tachykinins
R-HSA-1299308;Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)
R-HSA-1299287;Tandem pore domain halothane-inhibited K+ channel (THIK)
R-HSA-1296346;Tandem pore domain potassium channels
R-HSA-167243;Tat-mediated HIV elongation arrest and recovery
R-HSA-167246;Tat-mediated elongation of the HIV-1 transcript
R-HSA-174417;Telomere C-strand (Lagging Strand) Synthesis
R-HSA-174430;Telomere C-strand synthesis initiation
R-HSA-171319;Telomere Extension By Telomerase
R-HSA-157579;Telomere Maintenance
R-HSA-166665;Terminal pathway of complement
R-HSA-977068;Termination of O-glycan biosynthesis
R-HSA-5656169;Termination of translesion DNA synthesis
R-HSA-1474151;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
R-HSA-844615;The AIM2 inflammasome
R-HSA-844623;The IPAF inflammasome
R-HSA-844455;The NLRP1 inflammasome
R-HSA-844456;The NLRP3 inflammasome
R-HSA-1663150;The activation of arylsulfatases
R-HSA-2453902;The canonical retinoid cycle in rods (twilight vision)
R-HSA-1428517;The citric acid (TCA) cycle and respiratory electron transport
R-HSA-167826;The fatty acid cycling model
R-HSA-2514856;The phototransduction cascade
R-HSA-167827;The proton buffering model
R-HSA-2187335;The retinoid cycle in cones (daylight vision)
R-HSA-8852276;The role of GTSE1 in G2/M progression after G2 checkpoint
R-HSA-164952;The role of Nef in HIV-1 replication and disease pathogenesis
R-HSA-8849175;Threonine catabolism
R-HSA-456926;Thrombin signalling through proteinase activated receptors (PARs)
R-HSA-428930;Thromboxane signalling through TP receptor
R-HSA-209968;Thyroxine biosynthesis
R-HSA-210993;Tie2 Signaling
R-HSA-420029;Tight junction interactions
R-HSA-1222538;Tolerance by Mtb to nitric oxide produced by macrophages
R-HSA-1222387;Tolerance of reactive oxygen produced by macrophages
R-HSA-168142;Toll Like Receptor 10 (TLR10) Cascade
R-HSA-181438;Toll Like Receptor 2 (TLR2) Cascade
R-HSA-168164;Toll Like Receptor 3 (TLR3) Cascade
R-HSA-166016;Toll Like Receptor 4 (TLR4) Cascade
R-HSA-168176;Toll Like Receptor 5 (TLR5) Cascade
R-HSA-168181;Toll Like Receptor 7/8 (TLR7/8) Cascade
R-HSA-168138;Toll Like Receptor 9 (TLR9) Cascade
R-HSA-168179;Toll Like Receptor TLR1:TLR2 Cascade
R-HSA-168188;Toll Like Receptor TLR6:TLR2 Cascade
R-HSA-168898;Toll-Like Receptors Cascades
R-HSA-5250968;Toxicity of botulinum toxin type A (BoNT/A)
R-HSA-5250958;Toxicity of botulinum toxin type B (BoNT/B)
R-HSA-5250971;Toxicity of botulinum toxin type C (BoNT/C)
R-HSA-5250955;Toxicity of botulinum toxin type D (BoNT/D)
R-HSA-5250992;Toxicity of botulinum toxin type E (BoNT/E)
R-HSA-5250981;Toxicity of botulinum toxin type F (BoNT/F)
R-HSA-5250989;Toxicity of botulinum toxin type G (BoNT/G)
R-HSA-5250982;Toxicity of tetanus toxin (TeNT)
R-HSA-1679131;Trafficking and processing of endosomal TLR
R-HSA-399719;Trafficking of AMPA receptors
R-HSA-416993;Trafficking of GluR2-containing AMPA receptors
R-HSA-5624138;Trafficking of myristoylated proteins to the cilium
R-HSA-75944;Transcription from mitochondrial promoters
R-HSA-1362277;Transcription of E2F targets under negative control by DREAM complex
R-HSA-1362300;Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
R-HSA-167172;Transcription of the HIV genome
R-HSA-6781827;Transcription-Coupled Nucleotide Excision Repair (TC-NER)
R-HSA-69895;Transcriptional  activation of  cell cycle inhibitor p21 
R-HSA-8953750;Transcriptional Regulation by E2F6
R-HSA-3700989;Transcriptional Regulation by TP53
R-HSA-2151201;Transcriptional activation of mitochondrial biogenesis
R-HSA-69560;Transcriptional activation of p53 responsive genes  
R-HSA-2173793;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
R-HSA-8878171;Transcriptional regulation by RUNX1
R-HSA-8878166;Transcriptional regulation by RUNX2
R-HSA-8878159;Transcriptional regulation by RUNX3
R-HSA-5578749;Transcriptional regulation by small RNAs
R-HSA-8864260;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
R-HSA-452723;Transcriptional regulation of pluripotent stem cells
R-HSA-381340;Transcriptional regulation of white adipocyte differentiation
R-HSA-166020;Transfer of LPS from LBP carrier to CD14
R-HSA-917977;Transferrin endocytosis and recycling
R-HSA-72766;Translation
R-HSA-72649;Translation initiation complex formation
R-HSA-110320;Translesion Synthesis by POLH
R-HSA-5656121;Translesion synthesis by POLI
R-HSA-5655862;Translesion synthesis by POLK
R-HSA-110312;Translesion synthesis by REV1
R-HSA-110313;Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template
R-HSA-1445148;Translocation of GLUT4 to the plasma membrane
R-HSA-202430;Translocation of ZAP-70 to Immunological synapse
R-HSA-112315;Transmission across Chemical Synapses
R-HSA-112307;Transmission across Electrical Synapses 
R-HSA-174362;Transport and synthesis of PAPS
R-HSA-168874;Transport of HA trimer, NA tetramer and M2 tetramer from the endoplasmic reticulum to the Golgi Apparatus
R-HSA-72202;Transport of Mature Transcript to Cytoplasm
R-HSA-159231;Transport of Mature mRNA Derived from an Intronless Transcript
R-HSA-159236;Transport of Mature mRNA derived from an Intron-Containing Transcript
R-HSA-159234;Transport of Mature mRNAs Derived from Intronless Transcripts
R-HSA-168271;Transport of Ribonucleoproteins into the Host Nucleus
R-HSA-425366;Transport of bile salts and organic acids, metal ions and amine compounds
R-HSA-190827;Transport of connexins along the secretory pathway
R-HSA-190872;Transport of connexons to the plasma membrane
R-HSA-804914;Transport of fatty acids
R-HSA-159763;Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
R-HSA-432030;Transport of glycerol from adipocytes to the liver by Aquaporins
R-HSA-425393;Transport of inorganic cations/anions and amino acids/oligopeptides
R-HSA-83936;Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane
R-HSA-727802;Transport of nucleotide sugars
R-HSA-879518;Transport of organic anions
R-HSA-382551;Transport of small molecules
R-HSA-159230;Transport of the SLBP Dependant Mature mRNA
R-HSA-159227;Transport of the SLBP independent Mature mRNA
R-HSA-425397;Transport of vitamins, nucleosides, and related molecules
R-HSA-948021;Transport to the Golgi and subsequent modification
R-HSA-75109;Triglyceride biosynthesis
R-HSA-163560;Triglyceride catabolism
R-HSA-8979227;Triglyceride metabolism
R-HSA-450513;Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
R-HSA-5467348;Truncations of AMER1 destabilize the destruction complex
R-HSA-71240;Tryptophan catabolism
R-HSA-446107;Type I hemidesmosome assembly
R-HSA-427589;Type II Na+/Pi cotransporters
R-HSA-5689603;UCH proteinases
R-HSA-5602415;UNC93B1 deficiency - HSE
R-HSA-5689880;Ub-specific processing proteases
R-HSA-2142789;Ubiquinol biosynthesis
R-HSA-69601;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
R-HSA-75815;Ubiquitin-dependent degradation of Cyclin D
R-HSA-69229;Ubiquitin-dependent degradation of Cyclin D1
R-HSA-438066;Unblocking of NMDA receptor, glutamate binding and activation
R-HSA-162585;Uncoating of the HIV Virion
R-HSA-168336;Uncoating of the Influenza Virion
R-HSA-381119;Unfolded Protein Response (UPR)
R-HSA-176974;Unwinding of DNA
R-HSA-5339562;Uptake and actions of bacterial toxins
R-HSA-5210891;Uptake and function of anthrax toxins
R-HSA-5336415;Uptake and function of diphtheria toxin
R-HSA-70635;Urea cycle
R-HSA-77108;Utilization of Ketone Bodies
R-HSA-195399;VEGF binds to VEGFR leading to receptor dimerization
R-HSA-194313;VEGF ligand-receptor interactions
R-HSA-4420097;VEGFA-VEGFR2 Pathway
R-HSA-5218921;VEGFR2 mediated cell proliferation
R-HSA-5218920;VEGFR2 mediated vascular permeability
R-HSA-8866423;VLDL assembly
R-HSA-8964046;VLDL clearance
R-HSA-8866427;VLDLR internalisation and degradation
R-HSA-5619094;Variant SLC6A14 may confer susceptibility towards obesity
R-HSA-5619101;Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)
R-HSA-5660686;Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG)
R-HSA-432040;Vasopressin regulates renal water homeostasis via Aquaporins
R-HSA-388479;Vasopressin-like receptors
R-HSA-5653656;Vesicle-mediated transport
R-HSA-180585;Vif-mediated degradation of APOBEC3G
R-HSA-168325;Viral Messenger RNA Synthesis
R-HSA-168330;Viral RNP Complexes in the Host Cell Nucleus
R-HSA-192823;Viral mRNA Translation
R-HSA-168268;Virus Assembly and Release
R-HSA-2187338;Visual phototransduction
R-HSA-196819;Vitamin B1 (thiamin) metabolism
R-HSA-196843;Vitamin B2 (riboflavin) metabolism
R-HSA-199220;Vitamin B5 (pantothenate) metabolism
R-HSA-196836;Vitamin C (ascorbate) metabolism
R-HSA-196791;Vitamin D (calciferol) metabolism
R-HSA-8877627;Vitamin E
R-HSA-211916;Vitamins
R-HSA-964975;Vitamins B6 activation to pyridoxal phosphate
R-HSA-1296072;Voltage gated Potassium channels
R-HSA-180897;Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization
R-HSA-180910;Vpr-mediated nuclear import of PICs
R-HSA-180534;Vpu mediated degradation of CD4
R-HSA-5620916;VxPx cargo-targeting to cilium
R-HSA-3238698;WNT ligand biogenesis and trafficking
R-HSA-5340573;WNT ligand secretion is abrogated by the PORCN inhibitor LGK974
R-HSA-201688;WNT mediated activation of DVL
R-HSA-5140745;WNT5A-dependent internalization of FZD2, FZD5 and ROR2
R-HSA-5099900;WNT5A-dependent internalization of FZD4
R-HSA-8848584;Wax biosynthesis
R-HSA-5545619;XAV939 inhibits tankyrase, stabilizing AXIN
R-HSA-381038;XBP1(S) activates chaperone genes
R-HSA-211981;Xenobiotics
R-HSA-2032785;YAP1- and WWTR1 (TAZ)-stimulated gene expression
R-HSA-1606322;ZBP1(DAI) mediated induction of type I IFNs
R-HSA-435368;Zinc efflux and compartmentalization by the SLC30 family
R-HSA-442380;Zinc influx into cells by the SLC39 gene family
R-HSA-435354;Zinc transporters
R-HSA-450302;activated TAK1 mediates p38 MAPK activation
R-HSA-2046104;alpha-linolenic (omega3) and linoleic (omega6) acid metabolism
R-HSA-2046106;alpha-linolenic acid (ALA) metabolism
R-HSA-1307965;betaKlotho-mediated ligand binding
R-HSA-191647;c-src mediated regulation of Cx43 function and closure of gap junctions
R-HSA-418457;cGMP effects
R-HSA-192869;cRNA Synthesis
R-HSA-203615;eNOS activation
R-HSA-203765;eNOS activation and regulation
R-HSA-72187;mRNA 3'-end processing
R-HSA-72086;mRNA Capping
R-HSA-75072;mRNA Editing
R-HSA-75064;mRNA Editing: A to I Conversion
R-HSA-72200;mRNA Editing: C to U Conversion
R-HSA-72172;mRNA Splicing
R-HSA-72163;mRNA Splicing - Major Pathway
R-HSA-72165;mRNA Splicing - Minor Pathway
R-HSA-429958;mRNA decay by 3' to 5' exoribonuclease
R-HSA-430039;mRNA decay by 5' to 3' exoribonuclease
R-HSA-165159;mTOR signalling
R-HSA-166208;mTORC1-mediated signalling
R-HSA-77286;mitochondrial fatty acid beta-oxidation of saturated fatty acids
R-HSA-77288;mitochondrial fatty acid beta-oxidation of unsaturated fatty acids
R-HSA-372708;p130Cas linkage to MAPK signaling for integrins
R-HSA-171007;p38MAPK events
R-HSA-69563;p53-Dependent G1 DNA Damage Response
R-HSA-69580;p53-Dependent G1/S DNA damage checkpoint
R-HSA-69610;p53-Independent DNA Damage Response
R-HSA-69613;p53-Independent G1/S DNA damage checkpoint
R-HSA-193704;p75 NTR receptor-mediated signalling
R-HSA-193670;p75NTR negatively regulates cell cycle via SC1
R-HSA-209543;p75NTR recruits signalling complexes
R-HSA-193697;p75NTR regulates axonogenesis
R-HSA-193639;p75NTR signals via NF-kB
R-HSA-111995;phospho-PLA2 pathway
R-HSA-4839743;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
R-HSA-6793080;rRNA modification in the mitochondrion
R-HSA-6790901;rRNA modification in the nucleus and cytosol
R-HSA-72312;rRNA processing
R-HSA-8868766;rRNA processing in the mitochondrion
R-HSA-8868773;rRNA processing in the nucleus and cytosol
R-HSA-191859;snRNP Assembly
R-HSA-2033515;"t(4;14) translocations of FGFR3"
R-HSA-379724;tRNA Aminoacylation
R-HSA-6787450;tRNA modification in the mitochondrion
R-HSA-6782315;tRNA modification in the nucleus and cytosol
R-HSA-72306;tRNA processing
R-HSA-6785470;tRNA processing in the mitochondrion
R-HSA-6784531;tRNA processing in the nucleus
R-HSA-199992;trans-Golgi Network Vesicle Budding
R-HSA-4839744;truncated APC mutants destabilize the destruction complex
R-HSA-192814;vRNA Synthesis
R-HSA-192905;vRNP Assembly
